<SEC-DOCUMENT>0001193125-22-304962.txt : 20221215
<SEC-HEADER>0001193125-22-304962.hdr.sgml : 20221215
<ACCEPTANCE-DATETIME>20221214181219
ACCESSION NUMBER:		0001193125-22-304962
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20221214
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221215
DATE AS OF CHANGE:		20221214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALLIANT ENERGY CORP
		CENTRAL INDEX KEY:			0000352541
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRIC & OTHER SERVICES COMBINED [4931]
		IRS NUMBER:				391380265
		STATE OF INCORPORATION:			WI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-09894
		FILM NUMBER:		221463221

	BUSINESS ADDRESS:	
		STREET 1:		4902 NORTH BILTMORE LANE
		STREET 2:		SUITE 1000
		CITY:			MADISON
		STATE:			WI
		ZIP:			53718-2148
		BUSINESS PHONE:		608-458-3311

	MAIL ADDRESS:	
		STREET 1:		4902 NORTH BILTMORE LANE
		STREET 2:		SUITE 1000
		CITY:			MADISON
		STATE:			WI
		ZIP:			53718-2148

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERSTATE ENERGY CORP
		DATE OF NAME CHANGE:	19980427

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WPL HOLDINGS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d349058d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lnt="http://www.alliantenergy.com/20221214" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2022-12-14_to_2022-12-14" name="dei:EntityCentralIndexKey" contextRef="duration_2022-12-14_to_2022-12-14">0000352541</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2022-12-14_to_2022-12-14" name="dei:AmendmentFlag" contextRef="duration_2022-12-14_to_2022-12-14">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="lnt-20221214.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-12-14_to_2022-12-14"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000352541</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-14</xbrli:startDate> <xbrli:endDate>2022-12-14</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-12-14_to_2022-12-14">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-12-14_to_2022-12-14" format="ixt:date-monthname-day-year-en">December&#160;14, 2022</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2022-12-14_to_2022-12-14" name="dei:EntityRegistrantName">ALLIANT ENERGY CORP</ix:nonNumeric>ORATION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-12-14_to_2022-12-14" format="ixt-sec:stateprovnameen">Wisconsin</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-12-14_to_2022-12-14">1-9894</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-12-14_to_2022-12-14">39-1380265</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">file number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr> </table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2022-12-14_to_2022-12-14" name="dei:EntityAddressAddressLine1">4902 N. Biltmore Lane</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2022-12-14_to_2022-12-14" name="dei:EntityAddressCityOrTown">Madison</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2022-12-14_to_2022-12-14" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen">Wisconsin</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2022-12-14_to_2022-12-14" name="dei:EntityAddressPostalZipCode">53718</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-12-14_to_2022-12-14">608</ix:nonNumeric>) <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-12-14_to_2022-12-14">458-3311</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-12-14_to_2022-12-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-12-14_to_2022-12-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-12-14_to_2022-12-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-12-14_to_2022-12-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered&#160;pursuant to Section&#160;12(b) of the Act:</p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Alliant Energy Corporation, <ix:nonNumeric contextRef="duration_2022-12-14_to_2022-12-14" name="dei:Security12bTitle">Common Stock, $0.01 Par Value</ix:nonNumeric>, Trading Symbol: <ix:nonNumeric contextRef="duration_2022-12-14_to_2022-12-14" name="dei:TradingSymbol">LNT</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2022-12-14_to_2022-12-14" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter). Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-12-14_to_2022-12-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div> <p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="text-decoration:underline">Item&#160;1.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="text-decoration:underline">Entry into a Material Definitive Agreement.</span></p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&#160;14, 2022, Alliant Energy Corporation (the &#8220;Company&#8221;), entered into a distribution agreement (the &#8220;Distribution Agreement&#8221;) with Barclays Capital Inc., Mizuho Securities USA LLC and Wells Fargo Securities, LLC (each, an &#8220;Agent&#8221; and together, the &#8220;Agents&#8221;). Pursuant to the terms of the Distribution Agreement, the Company may sell from time to time through any Agent, as the Company&#8217;s sales agent, shares of the Company&#8217;s common stock, par value $0.01 per share, having an aggregate offering price of up to $225,000,000 (the &#8220;Shares&#8221;). Sales of the Shares, if any, will be made by means of ordinary brokers&#8217; transactions on the Nasdaq Global Select Market at market prices, in block transactions or as otherwise agreed by the Company and the Agents.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends to use the net proceeds from the sales of the Shares, after deducting the Agents&#8217; commission and offering expenses, for general corporate purposes, which may include repayment or refinancing of debt, working capital, construction and acquisition expenditures, investments and repurchases and redemptions of securities.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the Agreement, the Company may also sell Shares from time to time to any Agent as principal for its own account at a price to be agreed upon at the time of sale. Any sale of Shares to an Agent as principal would be pursuant to the terms of a separate terms agreement between the Company and such Agent.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Shares will be issued pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3</span> (Registration <span style="white-space:nowrap">No.&#160;333-251353).</span> The Company filed a prospectus supplement, dated December&#160;14, 2022, with the Securities and Exchange Commission in connection with the offer and sale of the Shares. You may obtain these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Company or the Agents will arrange to send you the prospectus supplement if you request it by contacting Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (888) <span style="white-space:nowrap">603-5847,</span> email: barclaysprospectus@broadridge.com; Mizuho Securities USA LLC, Attention: Equity Capital Markets, 1271 Avenue of the Americas, 3rd Floor, New York, NY 10020, telephone: (212) <span style="white-space:nowrap">205-7600,</span> email: <span style="white-space:nowrap">US-ECM@mizuhogroup.com;</span> and Wells Fargo Securities, LLC, Attention: Equity Syndicate Department, 500 West 33rd Street, New York, NY 10001, telephone: (833) <span style="white-space:nowrap">690-2713,</span> email: cmclientsupport@wellsfargo.com.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Agents and their respective affiliates have provided, and may in the future provide, a variety of financial and <span style="white-space:nowrap">non-financial</span> services to the issuer and to persons and entities with relationships with the issuer, for which they received or will receive customary fees and expenses. In particular, an affiliate of each of Barclays Capital Inc., Mizuho Securities USA LLC and Wells Fargo Securities, LLC is a lender under the Company&#8217;s credit facility.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of the Company&#8217;s common stock in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Distribution Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Distribution Agreement, a copy of which is filed herewith as Exhibit 1.1 and is incorporated by reference herein. A legal opinion relating to the Shares is filed herewith as Exhibit 5.1.</p></div></div> <p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="text-decoration:underline">Item&#160;9.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="text-decoration:underline">Financial Statements and Exhibits</span>.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;&#160;&#160;&#160;Exhibits</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap">Exhibit<br />No.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d349058dex11.htm">Distribution Agreement, dated December&#160;14, 2022, among Alliant Energy Corporation, Barclays Capital Inc., Mizuho Securities USA LLC and Wells Fargo Securities, LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d349058dex51.htm">Opinion of Perkins Coie LLP, with respect to the legality of the securities being registered. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d349058dex51.htm">Consent of Perkins Coie LLP (contained in Exhibit&#160;5.1 hereto). </a></td></tr></table></div></div> <p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, Alliant Energy Corporation has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0">
<tr>
<td style="width:45%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">ALLIANT ENERGY CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: December&#160;14, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert J. Durian</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Robert J. Durian</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President and Chief Financial Officer</td></tr></table></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d349058dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DISTRIBUTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">December&nbsp;14, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">745 7th Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1271 Avenue of the Americas, 3rd
Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">30 Hudson Yards, 14th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10001 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Alliant Energy
Corporation, a Wisconsin corporation (the&nbsp;&#147;<B>Company</B>&#148;), confirms its agreement with Barclays Capital Inc., Mizuho Securities USA LLC and Wells Fargo Securities, LLC (as agents and/or principals under any Terms Agreement (as
defined in Section&nbsp;1(a) below), each, an&nbsp;&#147;<B>Agent</B>&#148; and together, the&nbsp;&#147;<B>Agents</B>&#148;), with respect to the issuance and sale from time to time by the Company, in the manner and subject to the terms and
conditions described below in this Distribution Agreement (this&nbsp;&#147;<B>Agreement</B>&#148;), of Common Stock, $0.01 par value per share (the&nbsp;&#147;<B>Common Stock</B>&#148;), of the Company having an aggregate Gross Sales Price (as
defined in Section&nbsp;2(b) below) of up to $225,000,000 (the&nbsp;&#147;<B>Maximum Amount</B>&#148;) on the terms set forth in Section&nbsp;1 of this Agreement. Such shares are hereinafter collectively referred to as
the&nbsp;&#147;<B>Shares</B>&#148; and are described in the Prospectus referred to below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company has filed with the Securities and
Exchange Commission (the&nbsp;&#147;<B>Commission</B>&#148;) a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (No. <FONT STYLE="white-space:nowrap">333-251353)</FONT> (the&nbsp;&#147;<B>registration statement</B>&#148;)
for the registration of the Shares and other securities of the Company under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the&nbsp;&#147;<B>Act</B>&#148;); and such registration
statement sets forth the terms of the offering, sale and plan of distribution of the Shares and contains additional information concerning the Company and its business. Except where the context otherwise requires, &#147;<B>Registration
Statement</B>,&#148; as used herein, means the registration statement, as amended at the time of such registration statement&#146;s effectiveness for purposes of Section&nbsp;11 of the Act, as such section applies to the Agents, including
(1)&nbsp;all documents filed as a part thereof or incorporated or deemed to be incorporated by reference therein and (2)&nbsp;any information contained or incorporated by reference in a prospectus filed with the Commission pursuant to
Rule&nbsp;424(b) under the Act, to the extent such information is deemed, pursuant to Rule&nbsp;430B or Rule&nbsp;430C under the Act, to be part of the registration statement at the effective time. &#147;<B>Basic Prospectus</B>&#148; means the
prospectus dated December&nbsp;15, 2020 filed as part of the Registration Statement, including the documents incorporated by reference therein as of the date of such prospectus; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<B>Prospectus Supplement</B>&#148; means the most recent prospectus supplement relating to the Shares, to be filed by the Company with the Commission pursuant to Rule&nbsp;424(b) under the
Act on or before the second business day after the date of its first use in connection with a public offering or sale of Shares pursuant hereto (or such earlier time as may be required under the Act), in the form furnished by the Company to the
Agents in connection with the offering of the Shares; &#147;<B>Prospectus</B>&#148; means the Prospectus Supplement (and any additional prospectus supplement prepared in accordance with the provision of Section&nbsp;4(h) of this Agreement and filed
in accordance with the provisions of Rule&nbsp;424(b)) together with the Basic Prospectus attached to or used with the Prospectus Supplement; and &#147;<B>Permitted Free Writing Prospectus</B>&#148; has the meaning set forth in Section&nbsp;3(c).
Any reference herein to the Registration Statement, the Basic Prospectus, the Prospectus Supplement, the Prospectus or any Permitted Free Writing Prospectus shall, unless otherwise stated, be deemed to refer to and include the documents, if any,
incorporated by reference, or deemed to be incorporated by reference, therein (the&nbsp;&#147;<B>Incorporated Documents</B>&#148;), including, unless the context otherwise requires, the documents, if any, filed as exhibits to such Incorporated
Documents. Any reference herein to the terms &#147;amend,&#148; &#147;amendment&#148; or &#147;supplement&#148; with respect to the Registration Statement, the Basic Prospectus, the Prospectus Supplement, the Prospectus or any Permitted Free Writing
Prospectus shall, unless stated otherwise, be deemed to refer to and include the filing of any document under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the&nbsp;&#147;<B>Exchange
Act</B>&#148;) on or after the initial effective date of the Registration Statement, or the date of the Basic Prospectus, the Prospectus Supplement, the Prospectus or such Permitted Free Writing Prospectus, as the case may be, and deemed to be
incorporated therein by reference. References in this Agreement to financial statements or other information that is &#147;contained,&#148; &#147;included,&#148; &#147;described,&#148; &#147;set forth&#148; or &#147;provided&#148; in the
Registration Statement, the Basic Prospectus, the Prospectus Supplement, the Prospectus or any Permitted Free Writing Prospectus and any similar references shall, unless stated otherwise, include any information incorporated or deemed to be
incorporated by reference therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company and the Agents agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Issuance and Sale</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Upon the basis of the representations, warranties and agreements and subject to the terms and conditions set forth herein and provided the
Company provides the Agents with any due diligence materials and information reasonably requested by the Agents necessary for the Agents to satisfy their due diligence obligations, on any Exchange Business Day (as defined below) selected by the
Company, the Company and any one Agent shall enter into an agreement in accordance with Section&nbsp;2 hereof regarding the number of Shares to be placed by such Agent, as an agent, and the manner in which and other terms upon which such placement
is to occur (each such transaction being referred to as an&nbsp;&#147;<B>Agency Transaction</B>&#148;). For the avoidance of doubt, any Agency Transaction must be between the Company and a single Agent, and the Company may be party to only one
Agency Transaction at any given time during the term of the Distribution Agreement. The Company may also offer to sell the Shares directly to any Agent, as principal, in which event such parties shall enter into a separate agreement (each,
a&nbsp;&#147;<B>Terms Agreement</B>&#148;) in substantially the form of Exhibit&nbsp;A hereto (with such changes thereto as may be agreed upon by the Company and such Agent to accommodate a transaction involving additional underwriters), relating to
such sale in accordance with Section&nbsp;2(g) of this Agreement (each such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transaction being referred to as a&nbsp;&#147;<B>Principal Transaction</B>&#148;). As used herein, (i)&nbsp;the &#147;<B>Term</B>&#148; shall be the period commencing on the date hereof and
ending on the earlier of (x)&nbsp;the date on which the aggregate Gross Sales Price of Shares issued and sold pursuant to this Agreement and any Terms Agreements equals the Maximum Amount<B> </B>and (y)&nbsp;any termination of this Agreement
pursuant to Section&nbsp;8; (ii)&nbsp;an &#147;<B>Exchange Business Day</B>&#148; means any day during the Term that is a trading day for the Exchange other than a day on which trading on the Exchange is scheduled to close prior to its regular
weekday closing time; and (iii)&nbsp;&#147;<B>Exchange</B>&#148; means the Nasdaq Global Select Market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to the terms and
conditions set forth below, the Company appoints the Agents, as agents, in connection with the offer and sale of Shares in any Agency Transactions entered into hereunder. The Agents will use commercially reasonable efforts, consistent with their
normal trading and sales practices, to sell such Shares in accordance with the terms and subject to the conditions hereof and of the applicable Transaction Acceptance (as defined below). Neither the Company nor the Agents shall have any obligation
to enter into an Agency Transaction. The Company shall be obligated to issue and sell through any Agent, and such Agent shall be obligated to use commercially reasonable efforts, consistent with its normal trading and sales practices and as provided
herein and in the applicable Transaction Acceptance, to place Shares only if and when the Company makes a Transaction Proposal to such Agent related to such an Agency Transaction and a Transaction Acceptance related to such Agency Transaction has
been delivered to the Company by such Agent as provided in Section&nbsp;2 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Agent, as agent in any Agency Transaction,
hereby covenants and agrees not to make any sales of the Shares on behalf of the Company pursuant to this Agreement other than (A)&nbsp;by means of ordinary brokers&#146; transactions that qualify for delivery of a Prospectus in accordance with
Rule&nbsp;153 under the Act and meet the definition of an &#147;at the market offering&#148; under Rule&nbsp;415(a)(4) under the Act (such transactions are hereinafter referred to as &#147;<B>At the Market Offerings</B>&#148;), which may include
transactions directly on or through the Exchange or any other national securities exchange or facility thereof, a trading facility of a national securities association or an alternative trading system, and (B)&nbsp;such other sales of the Shares on
behalf of the Company in its capacity as agent of the Company as shall be agreed by the Company and such Agent in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If Shares
are to be sold in an Agency Transaction in an At the Market Offering, the respective Agent will confirm in writing to the Company the number of Shares sold on any Exchange Business Day and the related Gross Sales Price and Net Sales Price (as each
of such terms is defined in Section&nbsp;2(b) below) no later than the opening of trading on the immediately following Exchange Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If the Company shall default on its obligation to deliver Shares to any Agent pursuant to the terms of any Agency Transaction or Terms
Agreement, the Company shall (i)&nbsp;indemnify and hold harmless such Agent and its successors and assigns from and against any and all losses, claims, damages, liabilities and expenses arising from or as a result of such default by the Company and
(ii)&nbsp;notwithstanding any such default, pay to such Agent the commission to which it would otherwise be entitled in connection with such sale in accordance with Section&nbsp;2(b) below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company acknowledges and agrees that (i)&nbsp;there can be no assurance that any
Agent will be successful in selling the Shares; (ii)&nbsp;no Agent shall incur any liability or obligation to the Company or any other person or entity if it does not sell Shares for any reason other than a failure by such Agent to use its
commercially reasonable efforts consistent with its normal trading and sales practices and applicable law and regulations to sell such Shares in accordance with the terms of this Agreement; and (iii)&nbsp;no Agent shall be under any obligation to
purchase Shares on a principal basis pursuant to this Agreement, except as may otherwise be specifically agreed by such Agent and the Company in a Terms Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Transaction Acceptances and Terms Agreements</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company may, from time to time during the Term, propose to any Agent that they enter into an Agency Transaction to be executed on a
specified Exchange Business Day or over a specified period of Exchange Business Days, which proposal shall be made to such Agent by telephone or by email from any of the individuals listed as an authorized representative of the Company on
Schedule&nbsp;A hereto (which may be updated from time to time by certificate of the Company) and shall set forth the information specified below (each, a&nbsp;&#147;<B>Transaction Proposal</B>&#148;). If such Agent agrees to the terms of such
proposed Agency Transaction or if the Company and such Agent mutually agree to modified terms for such proposed Agency Transaction, then such Agent shall promptly deliver to the Company by email a notice (each, a&nbsp;&#147;<B>Transaction
Acceptance</B>&#148;) confirming the terms of such proposed Agency Transaction as set forth in such Transaction Proposal or setting forth the modified terms for such proposed Agency Transaction as agreed by the Company and such Agent, as the case
may be, whereupon such Agency Transaction shall become a binding agreement between the Company and such Agent. Each Transaction Proposal shall specify: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Exchange Business Day(s) on which the Shares subject to such Agency Transaction are intended to be sold
(each, a &#147;<B>Purchase Date</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the maximum number of Shares to be sold by such Agent (the &#147;<B>Specified Number of Shares</B>&#148;) on,
or over the course of, such Purchase Date(s), which shall not be more than 25% of the average daily trading volume reported for the Common Stock during the 30 Exchange Business Days preceding the date of the Transaction Proposal, or as otherwise
agreed between the Company and such Agent and documented in the relevant Transaction Acceptance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the lowest price, if any, at which the Company is willing to sell Shares on each such Purchase Date or a
formula pursuant to which such lowest price shall be determined (each, a &#147;<B>Floor Price</B>&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if other than 1.00% of the Gross Sales Price, such Agent&#146;s discount or commission. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Transaction Proposal shall not set forth a Specified Number of Shares that, when added to the aggregate number or aggregate Gross Sales Price of Shares
previously purchased and to be purchased pursuant to pending Transaction Acceptances (if any) hereunder and any Terms Agreements, results or could result in a total aggregate Gross Sales Price that exceeds the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Maximum Amount nor shall it set forth a Floor Price which is lower than the minimum price authorized from time to time by the Company&#146;s board of directors or, if permitted by applicable law
and the Company&#146;s charter and bylaws, a duly authorized committee thereof. The Company shall have responsibility for maintaining records with respect to the aggregate number and aggregate Gross Sales Price of Shares sold and for otherwise
monitoring the availability of Shares for sale under the Registration Statement and for insuring that the aggregate number and aggregate Gross Sales Price of Shares offered and sold does not exceed, and the price at which any Shares are offered or
sold is not lower than, the aggregate number and aggregate Gross Sales Price of Shares and the minimum price authorized from time to time by the Company&#146;s board of directors or, if permitted by applicable law and the Company&#146;s charter and
bylaws, a duly authorized committee thereof. In the event that more than one Transaction Acceptance with respect to any Purchase Date(s) is delivered by such Agent to the Company, the latest Transaction Acceptance shall govern any sales of Shares
for the relevant Purchase Date(s), except to the extent of any action occurring pursuant to a prior Transaction Acceptance and prior to the delivery to the Company of the latest Transaction Acceptance. The Company or an Agent may, upon notice to the
other parties by telephone (confirmed promptly by <FONT STYLE="white-space:nowrap">e-mail),</FONT> suspend or terminate the offering of the Shares pursuant to Agency Transactions for any reason; <U>provided</U>, <U>however</U>, that such suspension
or termination shall not affect or impair the parties&#146; respective obligations with respect to the Shares sold hereunder prior to the giving of such notice or their respective obligations under any Terms Agreement. Notwithstanding the foregoing,
if the terms of any Agency Transaction contemplate that Shares shall be sold on more than one Purchase Date, then the Company and such Agent shall mutually agree to such additional terms and conditions as they deem reasonably necessary in respect of
such multiple Purchase Dates, and such additional terms and conditions shall be set forth in or confirmed by, as the case may be, the relevant Transaction Acceptance and be binding to the same extent as any other terms contained therein. During any
term of suspension, the Company shall not be obligated to deliver (or cause to be delivered) any of the documents referred to in Section&nbsp;6(b) through (d), be deemed to affirm any of the representations and warranties contained in this Agreement
pursuant to Section&nbsp;3 or 6(a) hereof, or be obligated to conduct any due diligence session referred to in Section&nbsp;6(f), until the termination of the suspension and the recommencement of the offering of the Shares pursuant to this Agreement
(which recommencement shall constitute a Bring Down Delivery Date, as defined in Section&nbsp;6(b) below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Purchase Date(s) in
respect of the Shares deliverable pursuant to any Transaction Acceptance shall be set forth in or confirmed by, as the case may be, the applicable Transaction Acceptance. Except as otherwise agreed between the Company and any Agent, such
Agent&#146;s commission for any Shares sold through such Agent pursuant to this Agreement shall be a percentage equal to 1.00%,<B> </B>of the actual sales price of such Shares (the&nbsp;&#147;<B>Gross Sales Price</B>&#148;), which commission shall
be as set forth in or confirmed by, as the case may be, the applicable Transaction Acceptance; <U>provided</U>, <U>however</U>, that such commission shall not apply when such Agent acts as principal, in which case such commission or a discount shall
be set forth in the applicable Terms Agreement. Notwithstanding the foregoing, in the event the Company engages any Agent for a sale of Shares in an Agency Transaction that would constitute a &#147;distribution,&#148; within the meaning of Rule 100
of Regulation M under the Exchange Act, the Company will provide such Agent, at such Agent&#146;s request and upon reasonable advance notice to the Company, on or prior to the Settlement Date, the opinions of counsel, accountants&#146; letters and
officers&#146; certificates pursuant to Section&nbsp;5 hereof, each dated the Settlement Date, and such other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
documents and information as such Agent shall reasonably request, and the Company and such Agent will agree to compensation that is customary for the Agent with respect to such transaction. The
Gross Sales Price less the applicable Agent&#146;s commission and after deduction for any transaction fees, transfer taxes or similar taxes or fees imposed by any governmental, regulatory or self-regulatory organization in respect of the sale of the
applicable Shares is referred to herein as the&nbsp;&#147;<B>Net Sales Price</B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Payment of the Net Sales Price for Shares
sold by the Company on any Purchase Date pursuant to a Transaction Acceptance shall be made to the Company by wire transfer of immediately available funds to the account of the Company (which the Company shall provide to the applicable Agent at
least one Exchange Business Day prior to the applicable Agency Settlement Date (as defined below)) against delivery of such Shares to such Agent&#146;s account, or an account of such Agent&#146;s designee, at The Depository Trust Company through its
Deposit and Withdrawal at Custodian System (&#147;<B>DWAC</B>&#148;) or by such other means of delivery as may be agreed to by the Company and such Agent. Such payment and delivery shall be made at or about 10:00 a.m. (New York City time) on the
second Exchange Business Day (or such other day as may, from time to time, become standard industry practice for settlement of such a securities issuance or as agreed to by the Company and the applicable Agent) following each Purchase Date (each,
an&nbsp;&#147;<B>Agency Settlement Date</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If, as set forth in or confirmed by, as the case may be, the related Transaction
Acceptance, a Floor Price has been agreed to by the parties with respect to a Purchase Date, and the applicable Agent thereafter determines and notifies the Company that the Gross Sales Price for such Agency Transaction would not be at least equal
to such Floor Price, then the Company shall not be obligated to issue and sell through such Agent, and such Agent shall not be obligated to place, the Shares proposed to be sold pursuant to such Agency Transaction on such Purchase Date, unless the
Company and such Agent otherwise agree in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If either party has reason to believe that the exemptive provisions set forth in
Rule&nbsp;101(c)(1) of Regulation M under the Exchange Act are not satisfied with respect to the Shares, it shall promptly notify the other party and sales of the Shares under this Agreement, any Transaction Acceptance or any Terms Agreement shall
be suspended until that or other exemptive provisions have been satisfied in the judgment of each party. On or prior to the delivery of a prospectus that is required (whether physically or through compliance with Rule&nbsp;172 under the Act or any
similar rule) in connection with the offering or sale of the Shares, the Company shall calculate the average daily trading volume (as defined under &#147;<B>ADTV</B>&#148; by Rule 100 of Regulation M under the Exchange Act) of the Common Stock based
on market data provided by Bloomberg L.P. or such other sources as agreed upon by the Company and the applicable Agent. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) If the Company wishes to issue and sell the Shares pursuant to this Agreement but other than as set forth
in Section&nbsp;2(a) of this Agreement, it will notify the applicable Agent of the proposed terms of the Principal Transaction. If such Agent, acting as principal, wishes to accept such proposed terms (which it may decline to do for any reason in
its sole discretion) or, following discussions with the Company, wishes to accept amended terms, the Company and such Agent shall enter into a Terms Agreement setting forth the terms of such Principal Transaction. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(ii) The terms set forth in a Terms Agreement shall not be binding on the Company or the
applicable Agent unless and until the Company and such Agent have each executed and delivered such Terms Agreement accepting all of the terms of such Terms Agreement. In the event of a conflict between the terms of this Agreement and the terms of a
Terms Agreement, the terms of such Terms Agreement shall control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Each sale of the Shares to any Agent in a Principal Transaction
shall be made in accordance with the terms of this Agreement and a Terms Agreement, which shall provide for the sale of such Shares to, and the purchase thereof by, such Agent. A Terms Agreement may also specify certain provisions relating to the
reoffering of such Shares by such Agent. The commitment of any Agent to purchase the Shares pursuant to any Terms Agreement shall be deemed to have been made on the basis of the representations, warranties and agreements of the Company contained,
and shall be subject to the terms and conditions set forth, in this Agreement and such Terms Agreement. Any such Terms Agreement shall specify the number of the Shares to be purchased by the applicable Agent pursuant thereto, the price to be paid to
the Company for such Shares, any provisions relating to rights of, and default by, underwriters, if any, acting together with such Agent in the reoffering of the Shares, and the time and date (each such time and date being referred to herein as
a&nbsp;&#147;<B>Principal Settlement Date</B>&#148;; and, together with any Agency Settlement Date, a&nbsp;&#147;<B>Settlement Date</B>&#148;) and place of delivery of and payment for such Shares. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) Notwithstanding any other provision of this Agreement, the Company shall not offer, sell or deliver, or
request the offer or sale, of any Shares pursuant to this Agreement (whether in an Agency Transaction or a Principal Transaction) and, by notice to the Agents given by telephone (confirmed promptly by email), shall cancel any instructions for the
offer or sale of any Shares, and the Agents shall not be obligated to offer or sell any Shares, (i)&nbsp;during any period in which the Company is, or could be deemed to be, in possession of material
<FONT STYLE="white-space:nowrap">non-public</FONT> information; or (ii)&nbsp;during any period commencing on the date the Company shall issue a press release containing, or shall otherwise publicly announce, its earnings, revenues or other results
of operations (an &#147;<B>Earnings Announcement</B>&#148;) through and including the time that is 24 hours after the time that the Company files a Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or an Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> (a&nbsp;&#147;<B>Filing Time</B>&#148;) that includes consolidated financial statements as of and for the same period or periods, as the case may be, covered by such Earnings Announcement.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding clause&nbsp;(i) of Section&nbsp;2(h) hereof, if the Company wishes to offer or sell Shares to an
Agent as sales agent at any time during the period from and including an Earnings Announcement through and including the corresponding Filing Time, the Company shall first (A)&nbsp;prepare and deliver to such Agent (with a copy to counsel for the
Agents) a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that includes substantially the same financial and related information (together </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
with management&#146;s discussion and analysis thereof) that was included in such Earnings Announcement (other than any earnings projections and similar forward-looking data and officers&#146;
quotations) (each, an&nbsp;&#147;<B>Earnings <FONT STYLE="white-space:nowrap">8-K</FONT></B>&#148;), in form and substance reasonably satisfactory to such Agent, and, prior to its filing, obtain the written consent of such Agent to such filing
(which consent shall not be unreasonably withheld), (B)&nbsp;provide such Agent with the officers&#146; certificate, accountants&#146; letter and opinion and letter of counsel called for by Section&nbsp;6(b), 6(c) and 6(d) hereof, (C)&nbsp;afford
such Agent the opportunity to conduct a due diligence review in accordance with Section&nbsp;6(f) hereof prior to filing such Earnings <FONT STYLE="white-space:nowrap">8-K,</FONT> and (D)&nbsp;file such Earnings
<FONT STYLE="white-space:nowrap">8-K</FONT> with the Commission. For purposes of clarity, the parties hereto agree that (x)&nbsp;the delivery of any officers&#146; certificate, accountants&#146; letter or opinion and letter of counsel pursuant to
this Section&nbsp;2(h)(ii) shall not relieve the Company from any of its obligations under this Agreement with respect to any Quarterly Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> or Annual Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> as the case may be, including, without limitation, the obligation to deliver officers&#146; certificates, accountants&#146; letters and opinions and letters of counsel as provided in
Sections&nbsp;6(b), 6(c) and 6(d) hereof, and (y)&nbsp;this Section&nbsp;2(h)(ii) shall in no way affect or limit the operation of clause (i)&nbsp;of Section&nbsp;2(h)(i) hereof, which shall have independent application. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company agrees that any offer to sell, any solicitation of an offer to buy, or any sales of Shares by the Company shall be effected
only by or through the Agents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Anything in this Agreement to the contrary notwithstanding, the Company shall not authorize the
issuance and sale of, and the Agents, as sales agents, shall not be obligated to use their commercially reasonable efforts, consistent with their normal trading and sales practices, to sell, any Shares at a price lower than the minimum price, or in
a number or with an aggregate gross or net sales price in excess of the number or aggregate gross or net sales price, as the case may be, authorized from time to time to be issued and sold under this Agreement and any Terms Agreement, in each case
by the Company&#146;s board of directors or, if permitted by applicable law and the Company&#146;s charter and <FONT STYLE="white-space:nowrap">by-laws,</FONT> a duly authorized committee thereof, or in a number in excess of the number of Shares
approved for listing on the Exchange, or in excess of the number or amount of Shares available for issuance on the Registration Statement or as to which the Company has paid the applicable registration fee, it being understood and agreed by the
parties hereto that compliance with any such limitations shall be the sole responsibility of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations,
Warranties and Agreements of the Company</U>. The Company represents and warrants to, and agrees with, the Agents, on and as of (i)&nbsp;the date hereof; (ii)&nbsp;each date on which the Company receives a Transaction Acceptance
(the&nbsp;&#147;<B>Time of Acceptance</B>&#148;); (iii)&nbsp;each date on which the Company executes and delivers a Terms Agreement; (iv)&nbsp;each Time of Sale (as defined in Section&nbsp;3(a)); (v)&nbsp;each Settlement Date; and (vi)&nbsp;each
Bring-Down Delivery Date (as defined in Section&nbsp;6(b)) (each such date listed in (i)&nbsp;through (vi), a&nbsp;&#147;<B>Representation Date</B>&#148;), as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company meets the requirements for use of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Act. The Registration Statement is
an &#147;automatic shelf registration statement&#148; as defined under Rule 405 of the Act that automatically became effective not more than three years prior to the date hereof. No stop order suspending the use of the Registration Statement, the
Prospectus or any Permitted Free Writing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Prospectus has been issued under the Act and no proceedings for that purpose have been instituted or are pending or, to the knowledge of the Company, are contemplated by the Commission, and any
request on the part of the Commission for additional information has been complied with. The Company has not received from the Commission any notice pursuant to Rule&nbsp;401(g)(2) under the Act objecting to the use of the automatic shelf
registration statement form and the Company has not otherwise ceased to be eligible to use the automatic shelf registration form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the
respective times the Registration Statement became effective (including without limitation any effective dates of any amendments thereto and each deemed effective date with respect to the Agents pursuant to Rule&nbsp;430B(f)(2) of the Act) and at
each Representation Date, the Registration Statement and any amendments and supplements thereto complied or will comply, as the case may be, in all material respects with the requirements of the Act, and did not or will not, as the case may be,
contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. Neither the Prospectus nor any amendments or supplements thereto, at the time
the Prospectus or any such amendment or supplement was issued and at any Representation Date, included or will include an untrue statement of a material fact or omitted or will omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement or Prospectus made in reliance
upon and in conformity with information furnished to the Company in writing by the Agents expressly for use in the Registration Statement (or any amendment thereto) or Prospectus (or any amendment thereto), it being understood and agreed that the
only such information consists of the information appearing in the fifth paragraph under the caption &#147;Plan of Distribution&#148; in the Prospectus Supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each of the Basic Prospectus and the Prospectus Supplement filed as part of the Registration Statement as originally filed or as part of any
amendment thereto, or filed pursuant to Rule&nbsp;424 under the Act, complied when so filed in all material respects with the Act and each preliminary prospectus and the Prospectus delivered to the Agents for use in connection with this offering was
identical to the electronically transmitted copies thereof filed on the Commission&#146;s Electronic Data Gathering, Analysis and Retrieval system or any successor system thereto (collectively, &#147;<B>EDGAR</B>&#148;), except to the extent
permitted by Regulation <FONT STYLE="white-space:nowrap">S-T.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each Permitted Free Writing Prospectus, as of its issue date and at
all subsequent times through the completion of the public offer and sale of the Shares or until any earlier date that the Company notified or notifies the Agents as described in the next sentence, did not, does not and will not include any
information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including any document incorporated by reference therein and any preliminary or other prospectus deemed to be a
part thereof that has not been superseded or modified. If at any time following issuance of a Permitted Free Writing Prospectus there occurred or occurs an event or development as a result of which such Permitted Free Writing Prospectus included or
would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in the light of the circumstances, not misleading, the Company has notified or will notify promptly the Agents so that any use of such Permitted Free Writing Prospectus may cease until it is
amended or supplemented. The foregoing two sentences do not apply to statements in or omissions from any Permitted Free Writing Prospectus based upon and in conformity with written information furnished to the Company by the Agents expressly for use
therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As used herein, &#147;<B>Time of Sale</B>&#148; means (i)&nbsp;with respect to each offering of Shares pursuant to this
Agreement, the time of any Agent&#146;s initial entry into contracts with investors for the sale of such Shares and (ii)&nbsp;with respect to each offering of Shares pursuant to any relevant Terms Agreement, the time of sale of such Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At the time of filing the Registration Statement, at the time of the most recent amendment thereto for purposes of complying with
Section&nbsp;10(a)(3) of the Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section&nbsp;13 or 15(d) of the Exchange Act, or form of prospectus) and as of the date hereof, the Company was and is a
&#147;well known seasoned issuer&#148; as defined in Rule&nbsp;405 of the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Prior to the execution of this Agreement, the Company
has not, directly or indirectly, offered or sold any of the Shares by means of any &#147;prospectus&#148; (within the meaning of the Act) or used any &#147;prospectus&#148; (within the meaning of the Act) in connection with the offer or sale of the
Shares, in each case other than the Basic Prospectus. The Company represents and agrees that, unless it obtains the prior consent of the Agents, until the termination of this Agreement, it has not made and will not make any offer relating to the
Shares that would constitute an &#147;issuer free writing prospectus&#148; (as defined in Rule&nbsp;433 under the Act) or that would otherwise constitute a &#147;free writing prospectus&#148; (as defined in Rule&nbsp;405 under the Act) other than
any Permitted Free Writing Prospectus. Any such free writing prospectus relating to the Shares consented to by the Agents (including any Free Writing Prospectus prepared by the Company solely for use in connection with the offering contemplated by a
particular Terms Agreement) is herein referred to as a&nbsp;&#147;<B>Permitted Free Writing Prospectus</B>&#148;. The Company has complied and will comply in all material respects with the requirements of Rule&nbsp;433 under the Act applicable to
any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. The conditions set forth in one or more of subclauses&nbsp;(i) through (iv), inclusive, of Rule&nbsp;433(b)(1) under the
Act are satisfied, and the registration statement relating to the offering of the Shares contemplated hereby, as initially filed with the Commission, includes a prospectus that, other than by reason of Rule&nbsp;433 under the Act, satisfies the
requirements of Section&nbsp;10 of the Act; the Company is not disqualified, by reason of Rule&nbsp;164(f) or (g)&nbsp;under the Act, from using, in connection with the offer and sale of the Shares, &#147;free writing prospectuses&#148; (as defined
in Rule&nbsp;405 under the Act) pursuant to Rules&nbsp;164 and 433 under the Act; the Company was not as of each eligibility determination date for purposes of Rules&nbsp;164 and 433 under the Act with respect to the offering of the Shares
contemplated by the Registration Statement and this Agreement and is not an &#147;ineligible issuer&#148;. The Company has paid or, no later than the business day after the date of this Agreement, will pay the registration fee for the offering of
the Maximum Amount of Shares pursuant to Rule&nbsp;457 under the Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Incorporated Documents, at the time they were or hereafter are filed with the
Commission, complied or will comply, as the case may be, in all material respects with the requirements of the Exchange Act, and, when read together with the other information in the Registration Statement, the Prospectus and any Permitted Free
Writing Prospectus, did not or will not, as the case may be, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The description of
regulatory matters to which the Company is subject, as disclosed in the Company&#146;s filings with the Commission under the Exchange Act and as incorporated by reference into the Registration Statement, is true and correct in all material respects,
except to the extent such description in any specific filing has been superseded, updated or supplemented by such description in a subsequent filing under the Exchange Act made prior to the date hereof and incorporated by reference into the
Registration Statement or by such description in the Prospectus or any Permitted Free Writing Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The historical consolidated
financial statements of the Company and its consolidated subsidiaries and the related notes thereto included or incorporated by reference in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus present fairly in all
material respects the consolidated financial position of the Company and its consolidated subsidiaries at the dates indicated and the consolidated statements of income, changes in common equity and cash flows of the Company and its consolidated
subsidiaries for the periods specified. Said financial statements have been prepared in conformity with generally accepted accounting principles (&#147;<B>GAAP</B>&#148;) applied on a consistent basis throughout the periods presented. The supporting
schedules included in the Registration Statement, if any, present fairly in all material respects in accordance with GAAP the information required to be stated therein. The selected consolidated financial data and the summary consolidated financial
information included in the Prospectus and any Permitted Free Writing Prospectus present fairly in all material respects the information shown therein and have been compiled on a basis consistent with that of the audited financial statements
incorporated by reference in the Registration Statement. The other financial and statistical information and data included or incorporated by reference in the Registration Statement and the Prospectus are accurate and fairly presented in all
material respects, and prepared on a basis consistent with such financial statements and the books and records of the Company and its consolidated subsidiaries. No other financial statements are required by the Act or the Exchange Act to be included
or incorporated by reference in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Since the
respective dates as of which information is given in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus, except as otherwise stated therein, (i)&nbsp;there has not been any change in the capital stock (other than
shares of Common Stock issued or delivered pursuant to equity incentive, compensation and/or employee benefit plans of the Company and its consolidated subsidiaries (the&nbsp;&#147;<B>Company Stock Plans</B>&#148;) referred to in the Registration
Statement and the Prospectus or upon the conversion, vesting or exercise of options, rights and other securities granted thereunder, the issuance of Shares pursuant to this Agreement or any Terms Agreement, and the issuance of shares of Common Stock
pursuant to the Company&#146;s Shareowner Direct Plan or other dividend reinvestment plan referred to in the Registration Statement and the Prospectus) or short-term or long-term debt (except for borrowings and the repayment of borrowings in the
ordinary course of business); (ii)&nbsp;there has been no material adverse change in the condition, financial or otherwise, earnings or business affairs of the Company and its consolidated subsidiaries considered as one enterprise or on the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
performance by the Company of its obligations under this Agreement or any Terms Agreement, whether or not arising in the ordinary course of business, nor have there been any developments
involving a prospective material adverse change of the Company and its consolidated subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business (a&nbsp;&#147;<B>Material Adverse Effect</B>&#148;);
(iii)&nbsp;there have been no transactions entered into by the Company or any of its consolidated subsidiaries, other than those in the ordinary course of business, which are material with respect to the Company and its consolidated subsidiaries
considered as one enterprise, and (iv)&nbsp;except for regular dividends on the Common Stock, there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company has been duly organized and is validly existing as a corporation under the laws of the State of Wisconsin and has corporate
power and authority to own, lease and operate its properties and to conduct its business as described in the Prospectus and to enter into and perform its obligations under this Agreement; and the Company is duly qualified as a foreign corporation to
transact business and is in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in
good standing would not result in a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Each &#147;significant subsidiary&#148; of the Company (as such term is
defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;1-02</FONT> of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-X)</FONT> is listed on Exhibit&nbsp;21.1 to the Company&#146;s Annual Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended December&nbsp;31, 2021 (each such subsidiary shall be referred to herein as a&nbsp;&#147;<B>Significant Subsidiary</B>&#148; and, collectively, the&nbsp;&#147;<B>Significant
Subsidiaries</B>&#148;). Each Significant Subsidiary has been duly organized and is validly existing as a corporation or a limited liability company under the laws of the jurisdiction of its formation, has corporate or other power and authority to
own, lease and operate its properties and to conduct its business as described in the Prospectus and is duly qualified to transact business and is in good standing in each foreign jurisdiction in which such qualification is required, whether by
reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would not result in a Material Adverse Effect; except as otherwise disclosed in the Registration Statement,
all of the outstanding equity interests of each such Significant Subsidiary have been duly authorized and validly issued and all of the issued and outstanding shares of the capital stock of each such Significant Subsidiary are owned by the Company,
free and clear of any security interest, mortgage, pledge or lien that reasonably would be expected to result in a Material Adverse Effect. None of the outstanding equity interests of any Significant Subsidiary was issued in violation of the
preemptive or similar rights of any other holder of equity interests of such Significant Subsidiary that reasonably would be expected to result in a Material Adverse Effect. The only subsidiaries of the Company are (i)&nbsp;the Significant
Subsidiaries and (ii)&nbsp;certain other subsidiaries which do not constitute a &#147;significant subsidiary&#148; of the Company as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;1-02</FONT> of Regulation
<FONT STYLE="white-space:nowrap">S-X.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company has an authorized capitalization as set forth in the Registration Statement,
the Prospectus and any Permitted Free Writing Prospectus. All the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and
were not issued in violation of any preemptive or similar rights; except (i)&nbsp;as described in or expressly contemplated by the Registration Statement, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Prospectus and any Permitted Free Writing Prospectus and (ii)&nbsp;for options, restricted stock and performance shares and other awards granted pursuant to the Company Stock Plans, there are no
outstanding rights (including, without limitation, preemptive or similar rights), warrants or options to acquire, or instruments convertible into or exchangeable for, any shares of capital stock or other equity interests of the Company or any of its
consolidated subsidiaries, nor any contracts, commitments, agreements, understandings or arrangements of any kind relating to the issuance of any capital stock or other equity interest of the Company or any such subsidiary, any such convertible or
exchangeable securities or any such rights, warrants or options; and the capital stock of the Company and the Company&#146;s charter and bylaws conform in all material respects to the descriptions thereof contained in the Registration Statement, the
Prospectus and any Permitted Free Writing Prospectus; and all the outstanding shares of capital stock or other equity interests of each consolidated subsidiary owned, directly or indirectly, by the Company have been duly and validly authorized and
issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other
claim of any third party (each, a&nbsp;&#147;<B>Lien</B>&#148;), other than Liens that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is a &#147;holding company&#148; as defined
under the Public Utility Holding Company Act of 2005. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) With respect to the stock options, if any (the&nbsp;&#147;<B>Stock
Options</B>&#148;), granted pursuant to the stock-based compensation plans of the Company and its subsidiaries (the&nbsp;&#147;<B>Company Stock Plans</B>&#148;), (i)&nbsp;each Stock Option intended to qualify as an &#147;incentive stock option&#148;
under Section&nbsp;422 of the Internal Revenue Code of 1986, as amended (the&nbsp;&#147;<B>Code</B>&#148;), so qualifies; (ii)&nbsp;each grant of a Stock Option was duly authorized no later than the date on which the grant of such Stock Option was
by its terms to be effective (the&nbsp;&#147;<B>Grant Date</B>&#148;) by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any
required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto; (iii)&nbsp;each such grant was made in accordance in all
material respects with the terms of the Company Stock Plans, the Exchange Act and all other applicable laws and regulatory rules or requirements, including the rules of the Exchange and any other exchange on which Company securities are traded, and
(iv)&nbsp;each such grant was properly accounted for in accordance with GAAP in the financial statements (including the related notes) of the Company and disclosed in the Company&#146;s filings with the Commission in accordance with the Exchange Act
and all other applicable laws. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company of granting, Stock Options prior to, or otherwise coordinating the grant of Stock Options with, the release or
other public announcement of material information regarding the Company or its subsidiaries or their results of operations or prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The Company has all requisite corporate power and authority to execute and deliver this Agreement and any Terms Agreement and to perform
its obligations hereunder and thereunder; and all action required to be taken for the due and proper authorization, execution and delivery by the Company of this Agreement and any Terms Agreement and the consummation by it of the transactions
contemplated hereby and thereby has been duly and validly taken (or, in the case of any Terms Agreement, such action will have been duly and validly authorized). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) This Agreement has been duly authorized, executed and delivered by the Company and any
Terms Agreement will have been duly authorized, executed and delivered by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The Shares to be issued and sold by the
Company hereunder or under any Terms Agreement have been duly authorized by the Company and, when issued and delivered and paid for in the manner provided for herein or in any Terms Agreement, as the case may be, will be duly and validly issued,
will be fully paid and nonassessable and will conform to the description thereof in the Registration Statement, the Prospectus, and any Permitted Free Writing Prospectus. No holder of the Shares will be subject to personal liability by reason of
being such a holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) This Agreement conforms and each Terms Agreement will conform in all material respects to the description
thereof contained in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Neither the Company nor
any of its consolidated subsidiaries is (i)&nbsp;in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws;</FONT> (ii)&nbsp;in default in the performance or observance of any obligation, agreement, covenant or condition contained in
any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company or any of its consolidated subsidiaries is a party or by which it or any of them may be bound, or to which
any of the property or assets of the Company or any of its consolidated subsidiaries is subject (collectively, &#147;<B>Agreements and Instruments</B>&#148;) except for any such defaults with respect to this clause (ii)&nbsp;that would not result in
a Material Adverse Effect; and the execution, delivery and performance by the Company of this Agreement and any Terms Agreement, the consummation of the transactions contemplated herein and in the Registration Statement (including the issuance and
sale of the Shares and the use of proceeds from the sale of the Shares as described in the Prospectus), and compliance by the Company with its obligations hereunder do not and will not, whether with or without the giving of notice or passage of time
or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its
consolidated subsidiaries pursuant to, the Agreements and Instruments except for such conflicts, breaches or defaults or liens, charges or encumbrances that, singly or in the aggregate, would not result in a Material Adverse Effect, nor will such
action result in any violation of the provisions of (A)&nbsp;the charter or bylaws of the Company or any of its consolidated subsidiaries or (B)&nbsp;any applicable law, statute, rule, regulation, judgment, order, writ or decree of any government,
government instrumentality or court, domestic or foreign, having jurisdiction over the Company or any of its consolidated subsidiaries or any of their assets, properties or operations, except for any such violations with respect to this clause
(B)&nbsp;as would not, individually or in the aggregate, result in a Material Adverse Effect. As used herein, a &#147;<B>Repayment Event</B>&#148; means any event or condition which gives the holder of any note, debenture or other evidence of
indebtedness (or any person acting on such holder&#146;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its consolidated subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) No filing with, or authorization, approval, consent, license, order, registration,
qualification or decree of any court or governmental authority or agency is necessary or required for the performance by the Company of its obligations under this Agreement or any Terms Agreement, the consummation of the transactions contemplated by
this Agreement or any Terms Agreement, except (i)&nbsp;such as have been already obtained, (ii)&nbsp;such as may be required under the Act or state securities laws, and (iii)&nbsp;such consents, approvals or authorizations as may be required under
the rules of the Exchange or the rules of the Financial Industry Regulatory Authority (&#147;<B>FINRA</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) Except as described
in the Registration Statement and the Prospectus, there is no action, suit, proceeding, inquiry or investigation before or brought by any court or governmental agency or body, domestic or foreign, now pending, or, to the knowledge of the Company,
threatened, against or affecting the Company or any of its consolidated subsidiaries which might reasonably be expected to result in a Material Adverse Effect, or which might reasonably be expected to materially and adversely affect (i)&nbsp;the
properties or assets of the Company and its consolidated subsidiaries or (ii)&nbsp;the consummation of the transactions contemplated by this Agreement or any Terms Agreement, or the performance by the Company of its obligations hereunder or
thereunder. The aggregate of all pending legal or governmental proceedings to which the Company or any of its consolidated subsidiaries is a party or of which any of their respective property or assets is the subject which are not described in the
Prospectus, including ordinary routine litigation incidental to the business of the Company and its consolidated subsidiaries, could not reasonably be expected to result in a Material Adverse Effect. The Registration Statement is not the subject of
a pending proceeding or examination under Section&nbsp;8(d) or 8(e) of the Act, and the Company is not the subject of a pending proceeding under Section&nbsp;8A of the Act in connection with the offering of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) There are no contracts or documents which are required to be described in the Registration Statement or the Prospectus, or the documents
incorporated by reference therein or to be filed as exhibits thereto, which have not been so described and filed as required, except for this Agreement and an opinion of Perkins Coie LLP with respect to the validity of the Shares, which shall be
filed with the Commission as exhibits to a Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> in accordance with the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) Deloitte&nbsp;&amp; Touche LLP, which has audited certain financial statements of the Company and its consolidated subsidiaries and
delivered its report with respect to the audited financial statements of the Company and its consolidated subsidiaries and related schedules included or incorporated by reference in the Registration Statement and the Prospectus, is an independent
registered public accounting firm with respect to the Company and its consolidated subsidiaries as required by the Act and by the rules of the Public Company Accounting Oversight Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) The Company and its consolidated subsidiaries have good and marketable title to all real property owned by the Company and its
consolidated subsidiaries and good title to all other properties owned by them, in each case free and clear of all mortgages, pledges, liens, security interests, claims, restrictions or encumbrances of any kind except such as (i)&nbsp;are described
in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus or (ii)&nbsp;do not, singly or in the aggregate, materially affect the value of such property and do not interfere with the use made and proposed to be made of
such property by the Company or any of its consolidated subsidiaries; and all of the leases and subleases material to the business of the Company and its consolidated subsidiaries, considered as one enterprise, and under which the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company or any of its consolidated subsidiaries holds properties described in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus are in full force and effect, and
neither the Company nor any of its consolidated subsidiaries has any notice of any claim of any sort that has been asserted by anyone adverse to the rights of the Company or any of its consolidated subsidiaries under any of the leases or subleases
mentioned above, or affecting or questioning the rights of the Company or any of its consolidated subsidiaries to the continued possession of the leased or subleased premises under any such lease or sublease, except where such would not have a
Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the
one hand, and the directors, officers, security holders, customers or suppliers of the Company or any of its subsidiaries, on the other, that is required by the Act to be described in the Registration Statement and the Prospectus and that is not so
described in such documents and in any Permitted Free Writing Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) The Company is not and, upon the issuance and sale of the
Shares as herein contemplated and the application of the net proceeds therefrom as described in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus, will not be required to register as an &#147;investment
company&#148; under the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the&nbsp;&#147;<B>Investment Company Act</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) The Company and its consolidated subsidiaries have paid all federal, state, local and foreign taxes (other than those (i)&nbsp;that are
being contested in good faith and for which adequate reserves have been established in accordance with GAAP or (ii)&nbsp;that, if not paid, would not have a Material Adverse Effect) and filed (or obtained extensions with respect to) all tax returns
required to be paid or filed; and except as otherwise disclosed in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus, there is no tax deficiency that has been, or could reasonably be expected to be, asserted
against the Company or any of its consolidated subsidiaries or any of their respective properties or assets that would have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) The Company and its consolidated subsidiaries possess such permits, licenses, approvals, consents and other authorizations (collectively,
&#147;<B>Governmental Licenses</B>&#148;) issued by the appropriate federal, state, local or foreign governmental or regulatory agencies or bodies necessary to conduct the businesses now operated by them in the manner described in the Registration
Statement, the Prospectus and any Permitted Free Writing Prospectus, except where the failure to possess any such Governmental Licenses would not have a Material Adverse Effect. The Company and its consolidated subsidiaries are in compliance with
the terms and conditions of all such Governmental Licenses, except where the failure to so possess or comply would not, singly or in the aggregate, have a Material Adverse Effect. All of the Governmental Licenses are valid and in full force and
effect, except where the invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect would not have a Material Adverse Effect; and neither the Company nor any of its consolidated subsidiaries
has received any notice of proceedings related to the revocation or modification of any such Governmental Licenses which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse
Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) No labor dispute with the employees of the Company or any of its consolidated
subsidiaries exists or, to the knowledge of the Company, is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or any of its consolidated subsidiaries&#146; respective principal
suppliers, manufacturers, customers or contractors, which, in either case, would reasonably be expected to result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) Except as described in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus and except as would not, singly
or in the aggregate, result in a Material Adverse Effect, (i)&nbsp;neither the Company nor any of its consolidated subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule
of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation,
ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic
substances, hazardous substances, petroleum or petroleum products (collectively, &#147;<B>Hazardous Materials</B>&#148;) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials
(collectively, &#147;<B>Environmental Laws</B>&#148;); (ii)&nbsp;the Company and its consolidated subsidiaries have all permits, authorizations and approvals required under any applicable Environmental Laws and are each in compliance with their
requirements; (iii)&nbsp;there are no pending or, to the knowledge of the Company, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or
proceedings relating to any Environmental Law against the Company or any of its consolidated subsidiaries and (iv)&nbsp;there are no events or circumstances that might reasonably be expected to form the basis of an order for <FONT
STYLE="white-space:nowrap">clean-up</FONT> or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against or affecting the Company or any of its consolidated subsidiaries relating to Hazardous Materials
or any Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) Except for noncompliance that could not reasonably be expected to result in a Material Adverse Effect,
(i)&nbsp;each employee benefit plan, within the meaning of Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#147;<B>ERISA</B>&#148;), for which the Company or any member of its &#147;<B>Controlled
Group</B>&#148; (defined as any organization which is a member of a controlled group of corporations within the meaning of Section&nbsp;414 of the Internal Revenue Code of 1986, as amended (the&nbsp;&#147;<B>Code</B>&#148;)) would have any liability
(each, a&nbsp;&#147;<B>Plan</B>&#148;) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; (ii)&nbsp;no prohibited
transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a statutory or administrative exemption; (iii)&nbsp;for each Plan that
is subject to the funding rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, the minimum funding standard of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, as applicable, has been satisfied (without taking into account
any waiver thereof or extension of any amortization period) and is reasonably expected to be satisfied in the future (without taking into account any waiver thereof or extension of any amortization period); (iv) the fair value of the assets of each
Plan and the benefit obligations accrued under such Plan have been properly accounted for in accordance with GAAP on the financial statements of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company and its consolidated subsidiaries; (v)&nbsp;no &#147;reportable event&#148; (within the meaning of Section&nbsp;4043(c) of ERISA) has occurred or is reasonably expected to occur;
(vi)&nbsp;neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation
(&#147;<B>PBGC</B>&#148;), in the ordinary course and without default) in respect of a Plan (including a &#147;multiemployer plan&#148;, within the meaning of Section&nbsp;4001(a)(3) of ERISA); and (vii)&nbsp;there is no pending audit or
investigation by the Internal Revenue Service, the U.S. Department of Labor, the PBGC or any other governmental agency or any foreign regulatory agency with respect to any Plan. To the knowledge of the Company, none of the following events has
occurred or is reasonably likely to occur: (x)&nbsp;a material increase in the aggregate amount of contributions required to be made to all Plans by the Company or its consolidated subsidiaries in the current fiscal year of the Company and its
consolidated subsidiaries compared to the amount of such contributions made in the Company and its consolidated subsidiaries&#146; most recently completed fiscal year; or (y)&nbsp;a material increase in the Company and its consolidated
subsidiaries&#146; &#147;accumulated post-retirement benefit obligations&#148; (within the meaning of Statement of Financial Accounting Standards 106) compared to the amount of such obligations in the Company and its consolidated subsidiaries&#146;
most recently completed fiscal year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) The Company together with its consolidated subsidiaries maintains a system of internal
accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of
financial statements in conformity with GAAP and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; (iv)&nbsp;the recorded accountability for assets
is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences and (v)&nbsp;interactive data in eXtensible Business Reporting Language (&#147;<B>XBRL Data</B>&#148;) included or
incorporated by reference in the Registration Statement fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. Except as described in the
Registration Statement, the Prospectus and any Permitted Free Writing Prospectus, since the end of the Company&#146;s most recent audited fiscal year, there has been no material weakness in the Company&#146;s internal control over financial
reporting (whether or not remediated) and no change in the Company&#146;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#146;s internal control over financial
reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company together with its consolidated subsidiaries employs disclosure controls and procedures that are designed to ensure
that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#146;s rules and forms, and
is accumulated and communicated to the Company&#146;s management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding disclosure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) The Company and its consolidated subsidiaries have insurance covering their respective
properties, operations, personnel and businesses, which insurance is in amounts and insures against such losses and risks as are adequate to protect the Company and its consolidated subsidiaries and their respective businesses; and neither the
Company nor any of its consolidated subsidiaries has (i)&nbsp;received notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance or
(ii)&nbsp;any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) Neither the Company nor any of its consolidated subsidiaries nor, to the knowledge of the Company, any director, officer, agent,
employee, affiliate or other person acting on behalf of the Company or any of its consolidated subsidiaries, has (i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to domestic
political activity; (ii)&nbsp;made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any
government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office;
(iii)&nbsp;violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended (the&nbsp;&#147;<B>FCPA</B>&#148;), or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign
Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law; or (iv)&nbsp;made, offered, agreed to, requested or taken
an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have instituted
and maintain policies and procedures to ensure compliance with all applicable anti-bribery and anti-corruption laws. Neither the Company nor its consolidated subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee,
affiliate or other person acting on behalf of the Company or its consolidated subsidiaries will use any part of the proceeds from the sale of the Shares, directly or indirectly, in violation of the FCPA or the rules or regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee) The operations of the Company and its consolidated subsidiaries are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the Company or any of its
consolidated subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules or regulations issued, administered or enforced by any governmental agency (collectively, the&nbsp;&#147;<B>Anti-Money Laundering
Laws</B>&#148;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to
the knowledge of the Company, threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff) Neither the Company nor any of its consolidated subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or any of its consolidated subsidiaries is, or is controlled or 50% or more owned by or is acting on behalf of, an individual or entity that
is, currently the subject or the target of any sanctions administered or enforced by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Treasury (&#147;<B>OFAC</B>&#148;) or the U.S. Department of State and including, without limitation, the designation as a &#147;specially designated national&#148; or &#147;blocked
person&#148;), the United Nations Security Council (&#147;<B>UNSC</B>&#148;), the European Union, His Majesty&#146;s Treasury (&#147;<B>HMT</B>&#148;) or other relevant sanctions authority (collectively, &#147;<B>Sanctions</B>&#148;), nor is the
Company or any of its consolidated subsidiaries located, organized or resident in a country or territory that is currently the subject or target of Sanctions, including, without limitation, the <FONT STYLE="white-space:nowrap">so-called</FONT>
Donetsk People&#146;s Republic, the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic, and the Crimea regions of Ukraine, Cuba, Iran, North Korea and Syria (each, a&nbsp;&#147;<B>Sanctioned Country</B>&#148; and
together, the&nbsp;&#147;<B>Sanctioned Countries</B>&#148;); and the Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary,
joint venture partner or other person or entity (i)&nbsp;to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions; (ii)&nbsp;to fund or facilitate
any activities of or business in any Sanctioned Country; or (iii)&nbsp;in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise)
of Sanctions. As of the date hereof, the Company and its consolidated subsidiaries have not knowingly engaged in, are not now knowingly engaged in and will not knowingly engage in any dealings or transactions with any person that at the time of the
dealing or transaction is or was the subject or the target of Sanctions or with any of the Sanctioned Countries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(gg) Except as described
in or expressly contemplated by the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus, no consolidated subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument
to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiary&#146;s capital stock, from repaying to the Company any loans or advances to such subsidiary from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hh) Neither the Company nor any of its consolidated subsidiaries is a party to any contract, agreement or understanding with any person
(other than this Agreement or any Terms Agreement) that would give rise to a valid claim against the Company or any of its consolidated subsidiaries or the Agents for a brokerage commission, finder&#146;s fee or like payment in connection with the
offering and sale of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) No person has the right to require the Company or any of its consolidated subsidiaries to register
any securities for sale under the Act by reason of the filing of the Registration Statement with the Commission or the offering, issuance or sale of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jj) Neither the Company nor any consolidated subsidiary or affiliate of the Company has taken nor will the Company or any consolidated
subsidiary or affiliate of the Company take, directly or indirectly, any action which is designed to or which has constituted or which would reasonably be expected to cause or result in the stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kk) The application of the proceeds received by the Company from the
issuance, sale and delivery of the Shares as described in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other
regulation of such Board of Governors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ll) There is and has been no failure on the part of the Company or, to the knowledge of the
Company, any of the Company&#146;s directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith (the&nbsp;&#147;<B>Sarbanes Oxley
Act</B>&#148;), including Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(mm) Nothing has come to
the attention of the Company that has caused the Company to believe that the statistical and market-related data included in the Registration Statement, any Permitted Free-Writing Prospectus and the Prospectus is not based on or derived from sources
that are reliable and accurate in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(nn) All of the Shares that have been or may be sold under this Agreement and
any Terms Agreement have been approved for listing, subject only to official notice of issuance, on the Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(oo) The Common Stock
is an &#147;actively-traded security&#148; excepted from the requirements of Rule&nbsp;101 of Regulation M under the Exchange Act by Rule&nbsp;101(c)(1) thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(pp) Any certificate signed by any officer of the Company or any of its subsidiaries delivered to any Agent or to counsel to such Agent
pursuant to or in connection with this Agreement or any Terms Agreement shall be deemed a representation and warranty by the Company to such Agent as to the matters covered thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(qq) The Company and its subsidiaries&#146; information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications, and databases (collectively, &#147;<B>IT Systems</B>&#148;) are adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries
as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies,
procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive,
confidential or regulated data (&#147;<B>Personal Data</B>&#148;)) used in connection with their businesses, and there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied
without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and its subsidiaries are presently in material compliance with all applicable laws
or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and
to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(rr) The Company
acknowledges and agrees that the Agents have informed the Company that any Agent may, to the extent permitted under the Act and the Exchange Act, purchase and sell Shares for its own account while this Agreement is in effect, and shall be under no
obligation to purchase Shares on a principal basis pursuant to this Agreement, except as otherwise agreed by such Agent in the Transaction Proposal (as amended by the corresponding Transaction<B> </B>Acceptance, if applicable). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Certain Covenants of the Company.</U> The Company hereby agrees with the Agents: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For so long as the delivery of a prospectus is required (whether physically or through compliance with Rule 172 under the Act or any
similar rule) in connection with the offering or sale of Shares, before using or filing any Permitted Free Writing Prospectus and before using or filing any amendment or supplement to the Registration Statement, the Prospectus or any Permitted Free
Writing Prospectus (in each case, other than due to the filing of an Incorporated Document), to furnish to the Agents a copy of each such proposed Permitted Free Writing Prospectus, amendment or supplement within a reasonable period of time before
filing with the Commission or using any such Permitted Free Writing Prospectus, amendment or supplement and the Company will not use or file any such Permitted Free Writing Prospectus or any such proposed amendment or supplement to which any Agent
reasonably objects, unless the Company&#146;s legal counsel has advised the Company that use or filing of such document is required by law; and the Company will not use or file any such Permitted Free Writing Prospectus or proposed, amendment or
supplement to which any Agent reasonably objects unless the Company&#146;s legal counsel has advised the Company that use or filing of such document is required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To file the Prospectus, each Prospectus Supplement and any other amendments or supplements to the Prospectus pursuant to, and within the
time period required by, Rule 424(b) under the Act (without reference to Rule 424(b)(8)) and to file any Permitted Free Writing Prospectus to the extent required by Rule 433 under the Act and to provide copies of the Prospectus, each Prospectus
Supplement, any other amendments or supplements to the Prospectus and each Permitted Free Writing Prospectus (to the extent not previously delivered or filed on EDGAR) to the Agents via <FONT STYLE="white-space:nowrap">e-mail</FONT> in
&#147;.pdf&#148; format on such filing date to <FONT STYLE="white-space:nowrap">e-mail</FONT> accounts designated by the Agents and, at any Agent&#146;s request, to also furnish copies of the Prospectus, each Prospectus Supplement, any other
amendments or supplements to the Prospectus and each Permitted Free Writing Prospectus to each exchange or market on which sales were effected as may be required by the rules or regulations of such exchange or market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To file timely all reports and any definitive proxy or information statements required to be filed by the Company with the Commission
pursuant to Sections&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act for so long as the delivery of a prospectus is required (whether physically or through compliance with Rule 172 under the Act or any similar rule) in connection with the
offering or sale of the Shares, and during such same period to advise the Agents, promptly after the Company receives notice thereof, (i)&nbsp;of the time when any amendment to the Registration Statement has been filed or has become effective or any
supplement to the Prospectus or any Permitted Free Writing Prospectus or any amended Prospectus has been filed with the Commission; (ii)&nbsp;of the issuance by the Commission of any stop order or any order preventing or suspending the use of any
prospectus relating to the Shares or the initiation or threatening of any proceeding for that purpose, pursuant to Section&nbsp;8A of the Act; (iii)&nbsp;of any objection by the Commission to the use of Form
<FONT STYLE="white-space:nowrap">S-3ASR</FONT> by the Company pursuant to Rule&nbsp;401(g)(2) under the Act; (iv)&nbsp;of the suspension of the qualification of the Shares for offering or sale in any jurisdiction or of the initiation or threatening
of any proceeding for any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such purpose; (v)&nbsp;of any request by the Commission for the amendment of the Registration Statement or the amendment or supplementation of the Prospectus (in each case including any documents
incorporated by reference therein) or for additional information; (vi)&nbsp;of the occurrence of any event as a result of which the Prospectus or any Permitted Free Writing Prospectus as then amended or supplemented includes any untrue statement of
a material fact or omits to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus or any such Permitted Free Writing Prospectus is
delivered to a purchaser, not misleading; and (vii)&nbsp;of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event of the issuance of any such stop order or of any such order preventing or suspending the use of any such prospectus or
suspending any such qualification, or of any notice of objection pursuant to Rule&nbsp;401(g)(2) under the Act, to use promptly its commercially reasonable efforts to obtain its withdrawal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To furnish such information as may be required and otherwise cooperate in qualifying the Shares for offering and sale under the securities
or blue sky laws of such states or other jurisdictions as any Agent may reasonably designate and to maintain such qualifications in effect so long as required for the distribution of the Shares; <U>provided</U> that the Company shall not be required
to qualify as a foreign corporation, become a dealer of securities, or become subject to taxation in, or to consent to the service of process under the laws of, any such state or other jurisdictions (except service of process with respect to the
offering and sale of the Shares); and to promptly advise the Agents of the receipt by the Company of any notification with respect to the suspension of the qualification of the Shares for sale in any jurisdiction or the initiation of any proceeding
for such purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To make available to the Agents, at their respective offices in New York City, without charge, as soon as
reasonably practicable after the Registration Statement becomes effective, and thereafter from time to time to furnish to the Agents, as many copies of the Prospectus and the Prospectus Supplement (or of the Prospectus or Prospectus Supplement as
amended or supplemented if the Company shall have made any amendments or supplements thereto and documents incorporated by reference therein after the effective date of the Registration Statement) and each Permitted Free Writing Prospectus as the
Agents may reasonably request for so long as the delivery of a prospectus is required (whether physically or through compliance with Rule 172 under the Act or any similar rule); and for so long as this Agreement is in effect, the Company will
prepare and file promptly such amendment or amendments to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as may be necessary to comply with the requirements of Section&nbsp;10(a)(3) of the Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) To furnish or make available to the Agents during the Term (i)&nbsp;copies of any reports or other communications which the Company shall
send generally to its security holders or shall from time to time publish or publicly disseminate and, in each case, file with the Commission pursuant to the Exchange Act, and (ii)&nbsp;copies of all annual, quarterly and current reports filed with
the Commission on Forms <FONT STYLE="white-space:nowrap">10-K,</FONT> <FONT STYLE="white-space:nowrap">10-Q</FONT> and <FONT STYLE="white-space:nowrap">8-K,</FONT> or such other similar form as may be designated by the Commission, and to furnish to
any Agent from time to time during the Term such other information as such Agent may reasonably request regarding the Company or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
its subsidiaries, in each case as soon as reasonably practicable after such reports, communications, documents or information becomes available or promptly upon the request of such Agent, as
applicable; <U>provided</U>, <U>however</U>, that the Company shall have no obligation to provide the Agents with any document filed on EDGAR or included on the Company&#146;s Internet website. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) If, at any time during the Term, any event shall occur or condition shall exist as a result of which it is necessary in the reasonable
opinion of counsel for the Agents or counsel for the Company, to further amend or supplement the Prospectus or any Permitted Free Writing Prospectus as then amended or supplemented in order that the Prospectus or any such Permitted Free Writing
Prospectus will not include an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading, in light of the circumstances existing at the
time the Prospectus or any such Permitted Free Writing Prospectus is delivered to a purchaser, or if it shall be necessary, in the reasonable opinion of either such counsel, to amend or supplement the Registration Statement, the Prospectus or any
Permitted Free Writing Prospectus in order to comply with the requirements of the Act, in the case of such a determination by counsel to the Company, immediate notice shall be given, and confirmed in writing, to the Agents to cease the solicitation
of offers to purchase the Shares in each Agent&#146;s capacity as agent, and, in either case, the Company will, subject to Section&nbsp;4(a) above, promptly prepare and file with the Commission such amendment or supplement, whether by filing
documents pursuant to the Act, the Exchange Act or otherwise, as may be necessary to correct such untrue statement or omission or to make the Registration Statement, the Prospectus or any such Permitted Free Writing Prospectus comply with such
requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) To generally make available to its security holders as soon as reasonably practicable, but not later than 16 months
after the first day of each fiscal quarter referred to below, an earnings statement (in form complying with the provisions of Section&nbsp;11(a) under the Act and Rule&nbsp;158 of the Commission promulgated thereunder) covering each twelve-month
period beginning, in each case, not later than the first day of the Company&#146;s fiscal quarter next following each &#147;effective date&#148; (as defined in such Rule&nbsp;158) of the Registration Statement with respect to each sale of Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) To apply the net proceeds from the sale of the Shares in the manner described in the Prospectus Supplement under the caption
&#147;Use of Proceeds.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Not to, and to cause its subsidiaries not to, take, directly or indirectly, any action designed to cause
or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares; <U>provided</U> that nothing herein shall
prevent the Company from filing or submitting reports under the Exchange Act or issuing press releases in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Except as otherwise agreed between the Company and the Agents, to pay all costs, expenses, fees and taxes in connection with (i)&nbsp;the
preparation and filing of the Registration Statement, the Prospectus, any Permitted Free Writing Prospectus, and any amendments or supplements thereto, and the printing and furnishing of copies of each thereof to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Agents and to dealers (including costs of mailing and shipment); (ii)&nbsp;the registration, issue and delivery of the Shares; (iii)&nbsp;the qualification of the Shares for offering and sale
under the securities or blue sky laws of such states or other jurisdictions as the Agents may reasonably designate as aforesaid (including filing fees and the reasonable and documented legal fees and disbursements of a single outside counsel to the
Agents in connection therewith) and the printing and furnishing of copies of any blue sky surveys to the Agents; (iv)&nbsp;the listing of the Shares on the Exchange and any registration thereof under the Exchange Act; (v)&nbsp;any filing for review,
and any review, of the public offering of the Shares by FINRA (including filing fees and the reasonable and documented legal fees and disbursements of a single outside counsel to the Agents in connection therewith); (vi)&nbsp;the fees and
disbursements of counsel to the Company and of the Company&#146;s independent registered public accounting firm; (vii)&nbsp;the performance of the Company&#146;s other obligations hereunder and under any Terms Agreement; and (viii)&nbsp;the
reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses of the Agents, including the reasonable and documented fees and disbursements of a single outside counsel to the Agents
in connection with this Agreement and ongoing services in connection with the transactions contemplated hereunder. Except as otherwise provided in this Section&nbsp;4(l) the Agents will pay all of their own costs and expenses incurred in connection
with entering into this Agreement and the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) With respect to the offering(s) contemplated
by this Agreement or any Terms Agreement, the Company will not offer shares of Common Stock or any securities convertible into or exchangeable or exercisable for shares of the Common Stock in a manner in violation of the Act or the Exchange Act; and
the Company will not distribute any offering material in connection with the offer and sale of the Shares, other than the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus and any amendments or supplements thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) Unless the Company has given written notice to the Agents that the Company has suspended activity under this Agreement and there are no
pending Agency Transactions or Principal Transactions, the Company will not, without (A)&nbsp;giving the Agents at least three Exchange Business Days&#146; prior written notice specifying the nature of the proposed sale and the date of such proposed
sale<B> </B>and (B)&nbsp;the Agents suspending activity under this program for such period of time as requested by the Company or deemed appropriate by the Agents in light of the proposed sale, (i)&nbsp;offer, pledge, announce the intention to sell,
sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or other
equity securities of the Company or any securities convertible into or exercisable, redeemable or exchangeable for Common Stock or other equity securities of the Company, or file any registration statement under the Act with respect to any of the
foregoing (other than a registration statement on Form <FONT STYLE="white-space:nowrap">S-8,</FONT> a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> relating to the Company&#146;s Shareowner Direct Plan or other dividend
reinvestment plan or a or post-effective amendment to the Registration Statement) or (ii)&nbsp;enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of Common Stock or other equity
securities of the Company, whether any such transaction described in clause (i)&nbsp;or (ii) above is to be settled by delivery of shares of Common Stock or other securities, in cash or otherwise. The foregoing sentence shall not apply to
(A)&nbsp;the Shares to be offered and sold under this Agreement or any Terms Agreement, (B)&nbsp;any shares of Common </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock or other securities issued or delivered pursuant to any of the Company Stock Plans referred to in the Registration Statement and the Prospectus or upon the conversion, vesting or exercise
of options, rights or other securities granted thereunder, (C)&nbsp;any shares of Common Stock offered and sold pursuant to the Company&#146;s Shareowner Direct Plan or other dividend reinvestment plan referred to in the Registration Statement and
the Prospectus, or (D)&nbsp;any shares of Common Stock or other securities issuable upon the conversion, exercise or exchange of warrants or other securities outstanding on the first Trading Day prior to the delivery by the Company to the applicable
Agent of a Transaction Proposal to sell Shares hereunder and referred to in the Registration Statement and the Prospectus. Any <FONT STYLE="white-space:nowrap">lock-up</FONT> provisions relating to a Principal Transaction shall be set forth in the
applicable Terms Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each
Permitted Free Writing Prospectus that is not filed with the Commission in accordance with Rule&nbsp;433 under the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) The Company
will use commercially reasonable efforts to cause the Shares to be listed on the Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) The Company consents to any Agent trading
in the Common Stock for such Agents&#146; own account and for the account of such Agent&#146;s clients at the same time as sales of the Shares occur pursuant to this Agreement or any Terms Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) If immediately prior to the third anniversary (the&nbsp;&#147;<B>Renewal Deadline</B>&#148;) of the initial effective date of the
Registration Statement, the aggregate Gross Sales Price of Shares sold by the Company is less than the Maximum Amount and this Agreement has not expired or been terminated, the Company will, prior to the Renewal Deadline, file, if it has not already
done so and is eligible to do so, a new automatic shelf registration statement relating to the Shares, in a form reasonably satisfactory to the Agents. If the Company is no longer eligible to file an automatic shelf registration statement, the
Company will, prior to the Renewal Deadline, if it has not already done so, file a new shelf registration statement relating to the Shares, in a form reasonably satisfactory to the Agents, and will use its commercially reasonable efforts to cause
such registration statement to be declared effective within 60 days after the Renewal Deadline. The Company will take all other commercially reasonable action necessary or appropriate to permit the issuance and sale of the Shares to continue as
contemplated in the expired registration statement relating to the Shares. References herein to the Registration Statement shall include such new automatic shelf registration statement or such new shelf registration statement, as the case may be.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Execution of Agreement</U>. The Agents&#146; obligations under this Agreement shall be subject to the satisfaction of the following
conditions in connection with and on the date of the execution of this Agreement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Company shall have delivered to the Agents: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an officers&#146; certificate signed by two officers of the Company (one of whom shall be the Chief Financial
Officer or other senior financial officer) certifying as to the matters set forth in Exhibit B hereto; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an opinion and, if not covered in such opinion, a negative assurance letter of Perkins Coie LLP, counsel for
the Company, in the form of Exhibit C hereto (it being understood that such opinion will be subject to reasonable and customary assumptions, qualifications and exclusions); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;comfort&#148; letter from Deloitte&nbsp;&amp; Touche LLP, addressed to the Agents and dated the date of
this Agreement, addressing such matters as the Agents may reasonably request; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">evidence reasonably satisfactory to the Agents and their counsel that the Shares have been approved for listing
on the Exchange, subject only to notice of issuance on or before the date hereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">resolutions duly adopted by the Company&#146;s board of directors, and certified by an officer of the Company,
authorizing the Company&#146;s execution of this Agreement and the consummation by the Company of the transactions contemplated hereby, including the issuance and sale of the Shares; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such other documents as the Agents shall reasonably request; and </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Agents shall have received a letter or letters, which shall include legal opinions and negative assurance statements, of Gibson,
Dunn&nbsp;&amp; Crutcher LLP, counsel to the Agents, addressed to the Agents and dated the date of this Agreement, addressing such matters as the Agents may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Additional Covenants of the Company</U>. The Company further covenants and agrees with the Agents as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Transaction Proposal made by the Company that is accepted by the Agents by means of a Transaction Acceptance and each execution and
delivery by the Company of a Terms Agreement shall be deemed to be (i)&nbsp;an affirmation that the representations, warranties and agreements of the Company herein contained and contained in any certificate delivered to the Agents pursuant hereto
are true and correct at such Time of Acceptance or the date of such Terms Agreement, as the case may be, and (ii)&nbsp;an undertaking that such representations, warranties and agreements will be true and correct on any applicable Time of Sale and
Settlement Date, as though made at and as of each such time (it being understood that such representations, warranties and agreements shall relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and
supplemented to the time of such Transaction Acceptance or Terms Agreement, as the case may be). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each time that (i)&nbsp;except as
provided in the last sentence of Section&nbsp;2(a), the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus shall be amended or supplemented (including, except as noted in the proviso at the end of this Section&nbsp;6(b),
by the filing of any Incorporated Document); (ii)&nbsp;there is a Principal Settlement Date pursuant to a Terms Agreement; or (iii)&nbsp;except as provided in the last sentence of Section&nbsp;2(a), the Agents shall reasonably request upon
reasonable advance notice to the Company (each date referred to in clauses&nbsp;(i), (ii) and (iii)&nbsp;above and subject to the exceptions set forth therein, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a&nbsp;&#147;<B>Bring-Down Delivery Date</B>&#148;), the Company shall, unless the Agents agree otherwise, furnish or cause to be furnished to the Agents certificates, dated as of such Bring-Down
Delivery Date and delivered within five Exchange Business Days after the applicable Bring-Down Delivery Date or, in the case of a Bring-Down Delivery Date resulting from a Principal Settlement Date, delivered on such Principal Settlement Date, of
the same tenor as the certificate referred to in Section&nbsp;5(a)(i) hereof, modified as necessary to relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the time of delivery
of such certificates, or, in lieu of such certificate, certificate to the effect that the statements contained in the certificate referred to in Section&nbsp;5(a)(i) hereof furnished to Agents are true and correct as of such Bring-Down Delivery Date
as though made at and as of such date (except that such statements shall be deemed to relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the time of delivery of such
certificate); <U>provided</U>, <U>however</U>, that the filing of a Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> will not constitute a Bring-Down Delivery Date under clause&nbsp;(i) above unless either
(A)&nbsp;(x)&nbsp;such Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> is filed at any time during which either a Transaction Acceptance is binding and the Company has not suspended the use thereof (and prior to the settlement of
the Shares specified therein) or a prospectus relating to the Shares is required to be delivered under the Act (whether physically or through compliance with Rule&nbsp;172 under the Act or any similar rule) or such Current Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> is filed at any time from and including the date of a Terms Agreement through and including the related Settlement Date and (y)&nbsp;the Agents have reasonably requested that such date be deemed to be
a Bring-Down Delivery Date based upon the event or events reported in such Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> or (B)&nbsp;such Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> contains
capsule financial information, historical or pro forma financial statements, supporting schedules or other financial data that shall be deemed to be &#147;filed&#148; for purposes of Section&nbsp;18 of the Exchange Act; and <U>provided</U><I>,
</I><U>further</U><I>,</I> that an amendment or supplement to the Registration Statement or the Prospectus relating to the offering of other securities pursuant to the Registration Statement will not constitute a Bring-Down Delivery Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Bring-Down Delivery Date, the Company shall, unless the Agents agree otherwise, cause to be furnished to the Agents (A)&nbsp;the
written opinion and, if not included in such opinion, negative assurance letter of Perkins Coie LLP, counsel to the Company, dated as of the applicable Bring-Down Delivery Date and delivered within five<B> </B>Exchange Business Days after the
applicable Bring-Down Delivery Date or, in the case of a Bring-Down Delivery Date resulting from a Principal Settlement Date, dated and delivered on such Principal Settlement Date, of the same tenor as the opinion and letter referred to in
Section&nbsp;5(a)(ii) hereof, but modified as necessary to relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the time of delivery of such opinion and letter, or, in lieu of
such opinion and letter,<B> </B>such counsel shall furnish the Agents with a letter substantially to the effect that the Agents may rely on the opinion and letters of such counsel referred to in Section&nbsp;5(a)(ii), furnished to the Agents, to the
same extent as though they were dated the date of such letter authorizing reliance (except that statements in such last opinion and letter of such counsel shall be deemed to relate to the Registration Statement, the Prospectus or any Permitted Free
Writing Prospectus as amended and supplemented to the time of delivery of such letter authorizing reliance). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each Bring-Down Delivery Date, the Company shall, unless the Agents agree otherwise,
cause Deloitte&nbsp;&amp; Touche LLP to furnish to the Agents a &#147;comfort&#148; letter, dated as of the applicable Bring-Down Delivery Date and delivered within five<B> </B>Exchange Business Days after the applicable Bring-Down Delivery Date or,
in the case of a Bring-Down Delivery Date resulting from a Principal Settlement Date, delivered on such Principal Settlement Date, of the same tenor as the letter referred to in Section&nbsp;5(a)(iii) hereof, but modified to relate to the
Registration Statement, the Prospectus or any Permitted Free Writing Prospectus as amended and supplemented to the date of such letter, and, if the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus shall include or
incorporate by reference the financial statements of any entity or business (other than the consolidated financial statements of the Company and its subsidiaries), the Company shall, if requested by the Agents, cause a firm of independent public
accountants to furnish to the Agents a &#147;comfort&#148; letter, dated as of the applicable Bring-Down Delivery Date and delivered within five Exchange Business Days after the applicable Bring-Down Delivery Date or, in the case of a Bring-Down
Delivery Date resulting from a Principal Settlement Date, delivered on such Principal Settlement Date, addressing such matters as the Agents may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) At the time the Company delivers a Transaction Proposal to any Agent (i)&nbsp;no order suspending the effectiveness of the Registration
Statement shall be in effect, and no proceeding for such purpose or pursuant to Section&nbsp;8A under the Act shall be pending before or, to the knowledge of the Company, threatened by the Commission; the Prospectus and each Permitted Free Writing
Prospectus shall have been timely filed with the Commission under the Act (in the case of a Permitted Free Writing Prospectus, to the extent required by Rule 433 under the Act); and all requests by the Commission for additional information shall
have been complied with to the satisfaction of the Agents and no suspension of the qualification of the Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes, shall have
occurred and be in effect; and (ii)&nbsp;the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus shall not contain an untrue statement of material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as set
forth in the last sentence of Section&nbsp;2(a), the Company shall reasonably cooperate with any reasonable due diligence review requested by any Agent or its counsel from time to time in connection with the transactions contemplated hereby or any
Terms Agreement, including, without limitation, (i)&nbsp;at the commencement of each intended Purchase Date and any Time of Sale or Settlement Date, providing information and making available appropriate documents and appropriate corporate officers
of the Company and, upon reasonable request, representatives of Deloitte&nbsp;&amp; Touche LLP (and, if the Registration Statement, the Prospectus or any Permitted Free-Writing Prospectus shall include or incorporate by reference the financial
statements of any entity or business (other than the consolidated financial statements of the Company and its subsidiaries), representatives of the independent public accountants that audited or reviewed such financial statements) for an update on
diligence matters with representatives of such Agent and (ii)&nbsp;at each Bring-Down Delivery Date and otherwise as such Agent may reasonably request, providing information and making available documents and appropriate corporate officers of the
Company and representatives of Deloitte&nbsp;&amp; Touche LLP (and, if the Registration Statement, the Prospectus or any Permitted Free-Writing Prospectus shall include or incorporate by reference the financial statements of any entity or business
(other than the consolidated financial statements of the Company and its subsidiaries), representatives of the independent public accountants that audited or reviewed such financial statements) for one or more due diligence sessions with
representatives of such Agent and its counsel. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company shall disclose, in its Quarterly Reports on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> and in its Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> and, if requested by the Agents, in supplements to the Prospectus to be filed by the Company with the Commission from time to
time, the number of the Shares sold through the Agents under this Agreement and any Terms Agreement, and the gross and net proceeds to the Company from the sale of the Shares and the compensation paid by the Company with respect to sales of the
Shares pursuant to this Agreement during the relevant quarter or, in the case of any such prospectus supplement, such shorter period as the Agents may reasonably request or, in the case of an Annual Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> during the fiscal year covered by such Annual Report and the fourth quarter of such fiscal year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All opinions, letters and other documents referred to in Sections&nbsp;6(b) through (d)&nbsp;above shall be reasonably satisfactory in form
and substance to the Agent. The Agent will provide the Company with such notice (which may be oral, and in such case, will be confirmed via <FONT STYLE="white-space:nowrap">e-mail</FONT> as soon as reasonably practicable thereafter) as is reasonably
practicable under the circumstances when requesting an opinion, letter or other document referred to in Sections&nbsp;6(b) through (d)&nbsp;above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Conditions of the Agents&#146; Obligation</U>. The Agents&#146; obligation to solicit purchases on an agency basis for the Shares or
otherwise take any action pursuant to a Transaction Acceptance and to purchase the Shares pursuant to any Terms Agreement shall be subject to the satisfaction of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At the Time of Acceptance, at the time of the commencement of trading on the Exchange on the Purchase Date(s) and at the relevant Time of
Sale and Agency Settlement Date, or with respect to a Principal Transaction pursuant to a Terms Agreement, at the time of execution and delivery of the Terms Agreement by the Company and at the relevant Time of Sale and Principal Settlement Date:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The representations, warranties and agreements on the part of the Company herein contained or contained in any
certificate of an officer or officers or other authorized representative of the Company or any subsidiary of the Company delivered pursuant to the provisions hereof shall be true and correct in all respects. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall have performed and observed its covenants and other obligations hereunder and/or under any
Terms Agreement, as the case may be, in all material respects. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of an Agency Transaction, from the Time of Acceptance until the Agency Settlement Date, or, in the
case of a Principal Transaction pursuant to a Terms Agreement, from the time of execution and delivery of the Terms Agreement by the Company until the Principal Settlement Date, trading in the Common Stock on the Exchange shall not have been
suspended. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">From the date of this Agreement, no event or condition of a type described in Section&nbsp;3(f) hereof shall
have occurred or shall exist, which event or condition is not described in a Permitted Free Writing Prospectus (excluding any amendment or supplement thereto) or the Prospectus (excluding any amendment or supplement thereto) and the effect of which
in the judgment of the Agents makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the applicable Settlement Date on the terms and in the manner contemplated by this Agreement, any Terms Agreement,
any Permitted Free Writing Prospectus and the Prospectus. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subsequent to the relevant Time of Acceptance or, in the case of a Principal Transaction, subsequent to
execution of the applicable Terms Agreement, (A)&nbsp;no downgrading shall have occurred in the rating accorded any debt securities or preferred equity securities of or guaranteed by the Company or any of its consolidated subsidiaries by any
&#147;nationally recognized statistical rating organization&#148;, as such term is defined by the Commission for purposes of Section&nbsp;3(a)(62) of the Exchange Act and (B)&nbsp;no such organization shall have publicly announced that it has under
surveillance or review, or has changed its outlook with respect to, its rating of any debt securities or preferred equity securities of or guaranteed by the Company or any of its consolidated subsidiaries (other than an announcement with positive
implications of a possible upgrading) in each case that has not been described in the Prospectus or any Permitted Free Writing Prospectus issued prior to any related Time of Sale. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shares to be issued pursuant to the Transaction Acceptance or pursuant to a Terms Agreement, as applicable,
shall have been approved for listing on the Exchange, subject only to notice of issuance. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(A) No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted
or issued by any federal, state or foreign governmental or regulatory authority that would, as of the relevant Settlement Date, prevent the issuance or sale of the Shares and (B)&nbsp;no injunction or order of any federal, state or foreign court
shall have been issued that would, as of the relevant Settlement Date, prevent the issuance or sale of the Shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(A) No order suspending the effectiveness of the Registration Statement shall be in effect, no proceeding for
such purpose or pursuant to Section&nbsp;8A of the Act shall be pending before or threatened by the Commission and no notice of objection of the Commission to the use of the Registration Statement pursuant to Rule 401(g)(2) under the Act shall have
been received by the Company; (B)&nbsp;the Prospectus and each Permitted Free Writing Prospectus shall have been timely filed with the Commission under the Act (in the case of any Permitted Free Writing Prospectus, to the extent required by Rule 433
under the Act); (C) all </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
requests by the Commission for additional information shall have been complied with to the satisfaction of the Agents; and (D)&nbsp;no suspension of the qualification of the Shares for offering
or sale in any jurisdiction, and no initiation or threatening of any proceedings for any of such purposes, shall have occurred and be in effect. The Registration Statement, the Prospectus or any Permitted Free Writing Prospectus shall not contain an
untrue statement of material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading at the time any Agent delivers
a Transaction Acceptance to the Company or the Company and any Agent execute a Terms Agreement, as the case may be. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No amendment or supplement to the Registration Statement, the Prospectus or any Permitted Free Writing
Prospectus shall have been filed to which any Agent shall have reasonably objected in writing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Within five Exchange
Business Days after the applicable Bring-Down Delivery Date or, in the case of a Bring-Down Delivery Date resulting from a Principal Settlement Date, on such Principal Settlement Date, the Agents shall have received the officer&#146;s certificates,
opinions and negative assurance letters of counsel and &#147;comfort&#148; letters and other documents provided for under Sections&nbsp;6(b) through (d), inclusive. For purposes of clarity and without limitation to any other provision of this
Section&nbsp;7 or elsewhere in this Agreement, the parties hereto agree that the Agents&#146; obligations, if any, to solicit purchases of Shares on an agency basis or otherwise take any action pursuant to a Transaction Acceptance shall, unless
otherwise agreed in writing by the applicable Agent, be suspended during the period from and including a Bring-Down Delivery Date through and including the time that such Agent shall have received the documents described in the preceding sentence.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Within five Exchange Business Days after the applicable Bring-Down Delivery Date or, in the case of a Bring-Down Delivery Date
resulting from a Principal Settlement Date, on such Principal Settlement Date, with respect to which the Company is obligated to deliver a certificate described in Section&nbsp;6(b) hereof for which no waiver is applicable, Gibson, Dunn&nbsp;&amp;
Crutcher LLP, counsel for the Agents, shall have furnished to the Agents (or, in the case of a Principal Settlement Date, to the applicable Agent) such written opinion or opinions, dated as of such date, with respect to such matters as the Agents or
Agent, as applicable, may reasonably request, and such counsel shall have received such papers and information as they may reasonably request to enable them to pass upon such matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Termination</U>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) The Company may terminate this Agreement in its sole discretion at any time upon prior written notice to
the Agents. Any such termination shall be without liability of any party to any other party, except that (A)&nbsp;with respect to any pending sale, the obligations of the Company, including in respect of compensation of the Agents, shall remain in
full force and effect notwithstanding such termination; and (B)&nbsp;the provisions of Sections 3, 4 (except that if no Shares have been previously sold hereunder or under any Terms Agreement, only Section&nbsp;4(l)), 9, 13, 15 and 17 of this
Agreement shall remain in full force and effect notwithstanding such termination. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(ii) In the case of any sale by the Company pursuant to a Terms Agreement, the obligations
of the Company pursuant to such Terms Agreement and this Agreement may not be terminated by the Company without the prior written consent of the applicable Agent. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) The Agents may terminate this Agreement in their sole discretion at any time upon giving prior written
notice to the Company. Any such termination shall be without liability of any party to any other party, except that the provisions of Sections 3, 4 (except that if no Shares have been previously sold hereunder or under any Terms Agreement, only
Section&nbsp;4(l)), 9, 13, 15 and 17 of this Agreement shall remain in full force and effect notwithstanding such termination. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(ii) In the case of any purchase by any Agent pursuant to a Terms Agreement, the obligations of such Agent pursuant to such Terms Agreement
shall be subject to termination by such Agent at any time prior to or at the Principal Settlement Date if (A)&nbsp;since the time of execution of the Terms Agreement or the respective dates as of which information is given in the Registration
Statement, the Prospectus and any Permitted Free-Writing Prospectus, (i)&nbsp;trading generally shall have been suspended or materially limited on or by any of the New York Stock Exchange, the Nasdaq Stock Market, the Chicago Board Options Exchange,
the Chicago Mercantile Exchange or the Chicago Board of Trade; (ii)&nbsp;trading of any securities issued or guaranteed by the Company or any of its subsidiaries shall have been suspended on any exchange or in any
<FONT STYLE="white-space:nowrap">over-the</FONT> counter market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York state authorities; (iv)&nbsp;there shall have occurred any outbreak or
escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, solely in the case of events and conditions described in this clause&nbsp;(iv), in such Agent&#146;s judgment,
is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the terms and in the manner contemplated in the Prospectus or such Terms Agreement. If such Agent elects to terminate
its obligations pursuant to this Section&nbsp;8(b)(ii), the Company shall be notified promptly in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) This Agreement shall
remain in full force and effect until the earliest of (A)&nbsp;termination of the Agreement pursuant to Section&nbsp;8(a) or 8(b) above or otherwise by mutual written agreement of the parties, (B)&nbsp;such date that the Maximum Amount<B> </B>of
Shares has been sold in accordance with the terms of this Agreement and any Terms Agreements and (C)&nbsp;the first anniversary of the date of this Agreement, in each case except that the provisions of Section&nbsp;3, 4 (except that if no Shares
have been previously sold hereunder or under any Terms Agreement, only Section&nbsp;4(l)), 9, 13, 15 and 17 of this Agreement shall remain in full force and effect notwithstanding such termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Any termination of this Agreement shall be effective on the date specified in such
notice of termination; <U>provided</U> that, notwithstanding the foregoing, such termination shall not be effective until the close of business on the date of receipt of such notice by the Agents or the Company, as the case may be, or such later
date as may be required pursuant to Section&nbsp;8(a) or (b). If such termination shall occur prior to the Settlement Date for any sale of Shares, such sale shall settle in accordance with the provisions of Section&nbsp;2 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Indemnity and Contribution</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company agrees to indemnify and hold harmless the Agents, their respective affiliates, directors and officers and each person, if any,
who controls such Agents within the meaning of Section&nbsp;15 of the Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, reasonable out of pocket legal
fees and other reasonable expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), that arise out of, or are based upon, (i)&nbsp;any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement (or any amendment thereto) or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements
therein, not misleading or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Permitted Free Writing Prospectus (or any amendment or supplement
thereto), any &#147;issuer information&#148; filed or required to be filed pursuant to Rule&nbsp;433(d) under the Act or any road show as defined in Rule&nbsp;433(h) under the Act (a&nbsp;&#147;<B>road show</B>&#148;), or caused by any omission or
alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities
arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to the Agents furnished to the Company in writing by the Agents expressly
for use therein, it being understood and agreed that the only such information furnished by the Agents consists of the information described as such in subsection&nbsp;(b) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Agent, severally and not jointly, agrees to indemnify and hold harmless the Company, its directors and officers and each person, if
any, who controls the Company within the meaning of Section&nbsp;15 of the Act or Section&nbsp;20 of the Exchange Act to the same extent as the indemnity set forth in paragraph&nbsp;(a) above, but only with respect to any losses, claims, damages or
liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to the Agents furnished to the Company in writing by the
Agents expressly for use in the Registration Statement (or any amendment thereto), the Prospectus (or any amendment or supplement thereto), any Permitted Free Writing Prospectus (or any amendment or supplement thereto) or any road show, it being
understood and agreed upon that such information shall consist solely of the following: the information appearing in the fifth paragraph under the caption &#147;Plan of Distribution&#148; in the Prospectus Supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If any suit, action, proceeding (including any governmental or regulatory
investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either Section&nbsp;9(a) or 9(b) above, such person (the&nbsp;&#147;<B>Indemnified Person</B>&#148;) shall
promptly notify the person against whom such indemnification may be sought (the&nbsp;&#147;<B>Indemnifying Person</B>&#148;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall not relieve it from any liability that
it may have under this Section&nbsp;9 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>, <U>further</U>, that the failure to notify the
Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under this Section&nbsp;9. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have
notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to
represent the Indemnified Person and any others entitled to indemnification pursuant to this Section&nbsp;9 that the Indemnifying Person may designate in such proceeding and shall pay the fees and expenses of such counsel related to such proceeding,
as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i)&nbsp;the Indemnifying Person and the
Indemnified Person shall have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person shall have
reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such proceeding (including any impleaded parties)
included both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the
Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the reasonable fees and expenses of more than one separate firm (in addition to any local counsel) for (A)&nbsp;the Agents
and their respective affiliates, directors and officers and their respective control persons, if any, or (B)&nbsp;the Company, its directors, its officers who signed the Registration Statement and its control persons, if any, as the case may be, and
that all such reasonable fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for the Agents and their respective affiliates, directors and officers and their respective control persons, if any, shall be
designated in writing by the Agents, and any such separate firm for the Company, its directors, its officers who signed the Registration Statement and its control persons, if any, shall be designated in writing by the Company. The Indemnifying
Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified
Person from and against any loss or liability by reason of such settlement or judgment. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of
which any Indemnified Person is or could have been a party and indemnification is or could have been sought hereunder by such Indemnified Person, unless such settlement (x)&nbsp;includes an unconditional release of such Indemnified Person, in form
and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include any statement as to or any admission of fault, culpability or a failure to
act by or on behalf of any Indemnified Person. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested an Indemnifying Person to reimburse the Indemnified Person for fees and expenses of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
counsel as contemplated by this Section&nbsp;9(c), the Indemnifying Person agrees that it shall be liable for any settlement of any proceeding effected without its written consent if
(i)&nbsp;such settlement is entered into more than 30 days after receipt by such Indemnifying Person of the aforesaid request and (ii)&nbsp;such Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request
prior to the date of such settlement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the indemnification provided for in Sections&nbsp;9(a) and 9(b) above is unavailable to an
Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such Sections, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the
amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and any Agent, on
the other, from the offering of the Shares pursuant to this Agreement and any Terms Agreements or (ii)&nbsp;if the allocation provided by clause&nbsp;(i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only
the relative benefits referred to in clause&nbsp;(i) but also the relative fault of the Company, on the one hand, and any Agent, on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or
liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and any Agent, on the other, shall be deemed to be in the same respective proportions as the net proceeds (before
deducting expenses) received by the Company from the sale of the Shares pursuant to this Agreement and any Terms Agreements and the total discounts and commissions received by such Agent in connection therewith bear to the aggregate Gross Sales
Price of such Shares. The relative fault of the Company, on the one hand, and any Agent, on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or by such Agent, on the other hand, and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company and the Agents agree that it would not be just and equitable if contribution pursuant
to this Section&nbsp;9 were determined by <I>pro rata</I> allocation or by any other method of allocation that does not take account of the equitable considerations referred to in Section&nbsp;9(d) above. The amount paid or payable by an Indemnified
Person as a result of the losses, claims, damages and liabilities referred to in Section&nbsp;9(d) above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Person in
connection with any such action or claim. Notwithstanding the provisions of this Section&nbsp;9, in no event shall any Agent be required to contribute any amount in excess of the amount by which the total discounts and commissions received by such
Agent with respect to the offering of the Shares pursuant to this Agreement and any Terms Agreements exceeds the amount of any damages that such Agent has otherwise been required to pay by reason of such untrue or alleged untrue statement or
omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The remedies provided for in this Section&nbsp;9 are not exclusive and shall not limit
any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Notices</U>. All notices
and other communications under this Agreement and any Terms Agreement shall be in writing and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of communication, and, if to the Agents, shall be
sufficient in all respects if delivered or sent to (i)&nbsp;Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019, Attention: Syndicate Registration (fax: (646) <FONT STYLE="white-space:nowrap">834-8133),</FONT> with a copy, in the
case of any notice pursuant to Section&nbsp;9(c), to the Director of Litigation, Office of the General Counsel, Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019, (ii)&nbsp;Mizuho Securities USA LLC, ATTN: Equity Capital Markets,
1271 Avenue of the Americas, 3rd Floor, New York, NY 10020, and (iii)&nbsp;Wells Fargo Securities, LLC, 500 West 33rd Street, New York, NY 10001, Attention: Equity Syndicate Department (fax no: (212)
<FONT STYLE="white-space:nowrap">214-5918),</FONT> and, if to the Company, shall be sufficient in all respects if delivered or sent to it at 4902 North Biltmore Lane, Madison, Wisconsin 53718, Attn: Treasurer (email: MelissaKehoe@alliantenergy.com).
Notwithstanding the foregoing, Transaction Proposals shall be delivered by the Company to the Agents by telephone or email to (i)&nbsp;Barclays Capital Inc., 745 7th Avenue, New York, NY 10019, Attention: John Lembeck, Equity Capital Markets (email:
john.lembeck@barclays.com); (ii)&nbsp;Mizuho Securities USA LLC, Attention: Equity Capital Markets (telephone number: (212) <FONT STYLE="white-space:nowrap">205-7600;</FONT> email: <FONT STYLE="white-space:nowrap">US-ECM@mizuhogroup.com),</FONT> or
(iii)&nbsp;Wells Fargo Securities, LLC, Attention: Jennifer Lynch (email: Jennifer.R.Lynch@wellsfargo.com; telephone number: (212) <FONT STYLE="white-space:nowrap">214-6122),</FONT> Billy O&#146;Connell (email: william.oconnell@wellsfargo.com;
telephone number: (212) <FONT STYLE="white-space:nowrap">214-6127),</FONT> Josie Callanan (email: josie.callanan@wellsfargo.com; telephone number: (212) <FONT STYLE="white-space:nowrap">214-6128),</FONT> Michael Tiedemann (email:
michael.tiedemann@wellsfargo.com; telephone number: (212) <FONT STYLE="white-space:nowrap">214-6375)</FONT> and Kevin Fuller (email: kevin.fuller@wellsfargo.com; telephone number: (704) <FONT STYLE="white-space:nowrap">410-1134);</FONT> and
Transaction Acceptances shall be delivered by the Agents to the Company by email to Melissa Kehoe (email: MelissaKehoe@alliantenergy.com). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>No Fiduciary Relationship</U>. The Company acknowledges and agrees that the Agents are acting solely in the capacity of arm&#146;s
length contractual counterparties to the Company with respect to the offering of Shares contemplated hereby and any Terms Agreements (including in connection with determining the terms of the offering) and not as financial advisors or as fiduciaries
to, or agents of, the Company or any other person. Additionally, the Agents are not advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its
own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and the Agents shall have no responsibility or liability to the Company with respect
thereto. Any review by the Agents of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Agents and shall not be on behalf of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Adjustments for Stock Splits</U>. The parties acknowledge and agree that all share related numbers contained in this Agreement and the
average daily trading volume limitation set forth in Section&nbsp;2(a)(ii), any Transaction Proposal and any Transaction Acceptance shall be adjusted to take into account any stock split effected with respect to the Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Submission to Jurisdiction; Waiver of Jury Trial</U>. No proceeding related to this
Agreement or any Terms Agreement or any transactions contemplated hereby or thereby may be commenced, prosecuted or continued in any court other than the courts of the State of New York located in the City and County of New York or in the United
States District Court for the Southern District of New York, which courts shall have jurisdiction over the adjudication of such matters, and the parties consent to the jurisdiction of such courts and personal service with respect thereto. The
parties waive all right to trial by jury in any proceeding (whether based upon contract, tort or otherwise) in any way arising out of or relating to this Agreement or any Terms Agreement. The parties agree that a final judgment in any such
proceeding brought in any such court shall be conclusive and binding upon the parties and may be enforced in any other courts to whose jurisdiction the parties are or may be subject, by suit upon such judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Governing Law; Construction</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement, any Terms Agreement and any claim, counterclaim or dispute of any kind or nature whatsoever arising out of or in any way
relating to this Agreement or any Terms Agreement (each a&nbsp;&#147;<B>Claim</B>&#148;), directly or indirectly, shall be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Section headings in this Agreement and any Terms Agreement have been inserted as a matter of convenience of reference and are not a
part of this Agreement or any Terms Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Persons Entitled to Benefit of Agreement</U>. This Agreement and any Terms
Agreement shall inure to the benefit of and be binding upon the parties hereto and thereto, respectively, and their respective successors and the officers, directors, affiliates and controlling persons referred to in Section&nbsp;9 hereof. Nothing
in this Agreement or any Terms Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any such Terms Agreement or any provision contained herein or
therein. No purchaser of Shares from or through the Agents shall be deemed to be a successor merely by reason of purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.
<U>Counterparts</U>. This Agreement and any Terms Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall
constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures
and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Survival</U>. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the
Agents contained in this Agreement or any Terms Agreement or made by or on behalf of the Company or the Agents pursuant to this Agreement or any Terms Agreement or any certificate delivered pursuant hereto or thereto shall survive the delivery of
and payment for the Shares and shall remain in full force and effect, regardless of any termination of this Agreement or any Terms Agreement or any investigation made by or on behalf of the Company or the Agents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Certain Defined Terms</U>. For purposes of this Agreement, except where otherwise
expressly provided, the term &#147;affiliate&#148; has the meaning set forth in Rule&nbsp;405 under Act; the term &#147;business day&#148; means any day other than a day on which banks are permitted or required to be closed in New York City; and the
term &#147;subsidiary&#148; has the meaning set forth in Rule&nbsp;405 under the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Amendments or Waivers</U>. No amendment or
waiver of any provision of this Agreement or any Terms Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto or thereto as the case may
be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Recognition of the U.S. Special Resolution Regimes</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event that any Agent that is a Covered Entity (as defined below) becomes subject to a proceeding under a U.S. Special Resolution
Regime (as defined below), the transfer from such Agent of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime
if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Agent that is a Covered Entity or a BHC Act Affiliate (as defined below) of such Agent becomes subject to a
proceeding under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement that may be exercised against such Agent are permitted to be exercised to no greater extent than such Default Rights could be exercised under
the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For
purposes of this Section&nbsp;20: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>BHC Act Affiliate</B>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and
shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Covered Entity</B>&#148; means any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
252.82(b); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
47.3(b); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Default Right</B>&#148; has the meaning assigned to that term in, and shall be interpreted in
accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>U.S. Special Resolution Regime</B>&#148; means
each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder, and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Headings</U>. The headings herein are included for convenience of reference only and
are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I><B><I>[</I></B><I>Signature Page
Follows</I><B><I>]</I></B><I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing correctly sets forth the understanding between the Company and the Agents,
please so indicate in the space provided below for that purpose, whereupon this letter and your acceptance shall constitute a binding agreement among the Company and the Agents. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ALLIANT ENERGY CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: </TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Melissa Kehoe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Melissa Kehoe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Distribution Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted and agreed to as of the date first above written:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BARCLAYS CAPITAL INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: </TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Robert Stowe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Robert Stowe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MIZUHO SECURITIES USA LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: </TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Josh Weismer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Josh Weismer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WELLS FARGO SECURITIES, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: </TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Michael Tiedemann</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Michael Tiedemann</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Distribution Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Schedule&nbsp;A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Authorized Company Representatives </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert
Durian </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Melissa Kehoe </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Alliant Energy Corporation Common Stock </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERMS AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">_____________, 20__ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">745 7th Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1271 Avenue of the Americas, 3rd
Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">30 Hudson Yards, 14th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10001 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sirs: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Alliant Energy Corporation, a
Wisconsin corporation (the&nbsp;&#147;<B>Company</B>&#148;), proposes, subject to the terms and conditions stated herein and in the Distribution Agreement dated December&nbsp;14, 2022 (the&nbsp;&#147;<B>Distribution Agreement</B>&#148;) between the
Company and Barclays Capital Inc., Mizuho Securities USA LLC and Wells Fargo Securities, LLC (the&nbsp;&#147;<B>Agents</B>&#148;), to issue and sell to the Agents the securities specified in the Schedule hereto (the&nbsp;&#147;<B>Purchased
Securities</B>&#148;). Unless otherwise defined below, terms defined in the Distribution Agreement shall have the same meanings when used herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the provisions of the Distribution Agreement not specifically related to the solicitation by the Agents, as agents of the Company, of
offers to purchase securities is incorporated herein by reference in its entirety, and shall be deemed to be part of this Terms Agreement to the same extent as if such provisions had been set forth in full herein. Each of the representations,
warranties and agreements set forth therein shall be deemed to have been made as of the date of this Terms Agreement and the Settlement Date set forth in the Schedule hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An amendment to the Registration Statement or a supplement to the Prospectus, as the case may be, relating to the Purchased Securities, in the
form heretofore delivered to the Agents, is now proposed to be filed with the Securities and Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms
and conditions set forth herein and in the Distribution Agreement which are incorporated herein by reference, the Company agrees to issue and sell to the Agent, and the latter agrees to purchase from the Company, the Purchased Securities at the time
and place and at the purchase price set forth in the Schedule hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any provision of the Distribution Agreement or this Terms Agreement to the
contrary, the Company consents to the Agent trading in the Common Stock for the Agent&#146;s own account and for the account of its clients at the same time as sales of the Purchased Securities occur pursuant to this Terms Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I><B><I>[</I></B><I>Signature Page Follows</I><B><I>]</I></B><I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please sign and return to us a
counterpart hereof, whereupon this Terms Agreement, including those provisions of the Distribution Agreement incorporated herein by reference, shall constitute a binding agreement between the Agents and the Company. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ALLIANT ENERGY CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By: </P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted and agreed as of the date first above written:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BARCLAYS CAPITAL INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: </TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MIZUHO SECURITIES USA LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: </TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WELLS FARGO SECURITIES, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: </TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title:</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule to Terms Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of Purchased Securities: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Common Stock,
par value $0.01 per share </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Shares of Purchased Securities: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">[&#149;] shares </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Initial Price to Public: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">$[&#149;] per share </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Purchase Price Payable by
the Agent: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">$[&#149;] per share </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Method of
and Specified Funds for Payment of Purchase Price: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">By wire transfer to a bank account specified by the Company in same day funds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Method of Delivery: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the Agent&#146;s
account, or the account of the Agent&#146;s designee, at The Depository Trust Company via DWAC in return for payment of the purchase price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Settlement
Date: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">[&#149;], 20[&#149;] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Closing
Location: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">[&#149;] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Documents to be
Delivered: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following documents referred to in the Distribution Agreement shall be delivered on the Settlement Date as a condition to the closing for
the Purchased Securities (which documents shall be dated on or as of the Settlement Date and shall be appropriately updated to cover any Permitted Free Writing Prospectuses and any amendments or supplements to the Registration Statement, the
Prospectus, any Permitted Free Writing Prospectuses and any documents incorporated by reference therein): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) the officer&#146;s certificate referred to
in Section&nbsp;5(a)(i); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) the opinions and negative assurance letters of the Company&#146;s outside counsel and general counsel referred to in
Section&nbsp;5(a)(ii); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) the &#147;comfort&#148; letter referred to in Section&nbsp;5(a)(iii); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(4) the opinion and negative assurance letter referred to in Section&nbsp;5(b); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(5) such other documents as the Agent shall reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[Lockup:] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">[&#149;] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Time of sale: [&#149;] [a.m./p.m.] (New York City time) on [&#149;], [&#149;] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Time of sale information: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The number of shares of Purchased Securities set forth above </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The initial price to public set forth above </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>[Other]</B> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>OFFICERS&#146; CERTIFICATE </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated
__________, 20__ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We, Melissa Kehoe, the Treasurer of Alliant Energy Corporation, a Wisconsin corporation
(the&nbsp;&#147;<B>Company</B>&#148;), and Robert J. Durian, the Executive Vice President and Chief Financial Officer of the Company, do hereby certify that this certificate is signed by us pursuant to the Distribution Agreement dated
December&nbsp;14, 2022 between the Company and Barclays Capital Inc., Mizuho Securities USA LLC and Wells Fargo Securities, LLC (the&nbsp;&#147;<B>Agreement</B>&#148;), and do hereby further certify on behalf of the Company, as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The representations and warranties of the Company in the Agreement are true and correct on and as of the date hereof as though made on and
as of this date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. The Company has performed all obligations and satisfied all covenants and conditions on its part to be performed or
satisfied pursuant to the Agreement on or prior to the date hereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Since the respective dates as of which information is given in the
Registration Statement, the Prospectus and any Permitted Free Writing Prospectus, except as otherwise stated therein, (i)&nbsp;neither the Company nor any of its consolidated subsidiaries has entered into any transaction or agreement (whether or not
in the ordinary course of business) that is material to the Company and its consolidated subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Company and its consolidated subsidiaries
taken as a whole; and (ii)&nbsp;neither the Company nor any of its consolidated subsidiaries has sustained any loss or interference with its business that is material to the Company and its consolidated subsidiaries taken as a whole and that is
either from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I><B><I>[</I></B><I>Signature Page Follows</I><B><I>]</I></B><I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Melissa Kehoe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: Treasurer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Robert J. Durian</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: Executive Vice President and Chief Financial Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF OPINION AND NEGATIVE ASSURANCE STATEMENT OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PERKINS COIE LLP, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COUNSEL TO THE COMPANY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinions
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1 The Registration Statement [has/and any post-effective amendments thereto have] become effective under the Act. The Prospectus
[has/and any supplements thereto have] been filed pursuant to Rule 424(b) under the Act in the manner and within the time period required by such Rule 424(b) (without reference to Rule 424(b)(8)). Any required filing of any Permitted Free Writing
Prospectus listed on Schedule 1 hereto has been made in the manner and within the time period required by Rule 433 under the Act. To our knowledge, no order suspending the effectiveness of the Registration Statement has been issued and no proceeding
for that purpose has been instituted or is pending or threatened by the Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2 Without independent verification of the factual
accuracy, completeness or fairness of any statements made in the Registration Statement and the Prospectus, each of the Registration Statement and the Prospectus (except for the financial statements and financial schedules and other financial or
accounting information included therein or omitted therefrom and for management&#146;s report on the Company&#146;s internal control over financial reporting included therein and the Statement of Eligibility of the Trustee on Form <FONT
STYLE="white-space:nowrap">T-1</FONT> under the Trust Indenture Act of 1939, as amended (the&nbsp;&#147;<B><I>Trust Indenture Act</I></B>&#148;), as to which we express no opinion) appear on its face to be appropriately responsive in all material
respects with the requirements of the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3 The Company is a corporation validly existing under the laws of the State of Wisconsin. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4 The Company has the corporate power and corporate authority necessary to own, lease and operate its properties and to conduct its business
as described in the Registration Statement and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5 The Shares conform in all material respects to the description thereof
set forth or incorporated by reference in the Registration Statement and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6 The Company has the corporate power to enter
into and perform the Distribution Agreement <B>[Add the following if opinion is delivered in connection with a Terms Agreement &#151;</B> ; and the Company has the corporate power to enter into and perform the Subject Agreement<B>]</B>. The
Distribution Agreement has been duly authorized by all necessary corporate action on the part of the Company, and has been duly executed and delivered by the Company <B>[Add the following if opinion is delivered in connection with a Terms
Agreement&#151; </B>and the Subject Agreement has been duly authorized by all necessary corporate action on the part of the Company, and has been duly executed and delivered by the Company<B>]</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7 All of the Shares <B>[Add the following if opinion is delivered in connection with a Terms
Agreement&#151; </B>(including, without limitation, the Shares to be issued and sold pursuant to the Subject Agreement)<B>]</B> have been duly authorized for issuance and sale pursuant to the Distribution Agreement, and when issued and delivered by
the Company pursuant to the Distribution Agreement <B>[Add the following if opinion is delivered in connection with a Terms Agreement&#151; </B>and, in the case of the Shares to be issued and sold pursuant to the Subject Agreement, in accordance
with the terms of the Subject Agreement<B>]</B> against payment of the consideration set forth therein, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8 No shareholder of the Company or any other person has any preemptive right, right of first refusal or other similar rights to subscribe for
or purchase securities of the Company created under or pursuant to the Charter Documents or the Wisconsin Business Corporation Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9 The
Company&#146;s execution, delivery and performance of its obligations in the Distribution Agreement <B>[Add the following if opinion is delivered in connection with a Terms Agreement&#151; </B>and<B> </B>the Subject Agreement<B>] </B>do not: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) violate statutory laws that counsel exercising customary professional judgment would in our experience reasonably recognize
as typically applicable to agreements similar to the Distribution Agreement <B>[Add the following if opinion is delivered in connection with a Terms Agreement&#151; </B>and<B> </B>the Subject Agreement<B>] </B>and transactions similar to those
contemplated by the Distribution Agreement <B>[Add the following if opinion is delivered in connection with a Terms Agreement&#151; </B>and<B> </B>the Subject Agreement<B>]</B>, except for such violations that, according to the <FONT
STYLE="white-space:nowrap">Back-Up</FONT> Certificate, would not, individually or in the aggregate, have a Material Adverse Effect; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) violate the Charter Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) breach or result in a default or Repayment Event under any Material Agreement, except for such breaches, defaults or
Repayment Events that, according to the <FONT STYLE="white-space:nowrap">Back-Up</FONT> Certificate would not, individually or in the aggregate, have a Material Adverse Effect; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) breach or violate any Material Court Order, except for such breaches or violations that, according to the <FONT
STYLE="white-space:nowrap">Back-Up</FONT> Certificate, would not, individually or in the aggregate, have a Material Adverse Effect; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) violate Regulation T, U or X of the Board of Governors of the Federal Reserve System, provided in rendering this opinion as
to such regulations we have assumed that (i)&nbsp;no credit is extended or maintained under the Distribution Agreement <B>[Add the following if opinion is delivered in connection with a Terms Agreement&#151; </B>or<B> </B>the Subject Agreement<B>]
</B>by a U.S. broker-dealer or other &#147;creditor&#148; (as defined in Regulation T) or &#147;foreign branch of a broker-dealer&#148; (within the meaning of Regulation X), and (ii)&nbsp;no proceeds from the sale of the Shares will be used for the
immediate purpose of buying or carrying margin stock (within the meaning of Regulation U). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Material
Agreement</B>&#148; means any agreement identified by the Company as a material agreement in its <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> filing with the Commission for the Company&#146;s fiscal year ended December&nbsp;31, 2021.
&#147;<B>Material Court Order</B>&#148; means the court orders listed on Schedule&nbsp;2 hereto, which list was provided by the Company in response to our request for a list of all material court orders binding on the Company or its property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10 All consents, approvals, authorizations or other orders of, or registrations or filings
on the part of the Company with any United States federal or Wisconsin State governmental or regulatory authority required for the issuance of the Shares have been made or obtained, or will be effective, except for (1)&nbsp;such approvals of the
Nasdaq Global Select Market (the&nbsp;&#147;<B><I>Exchange</I></B>&#148;) as have been obtained, subject to official notice of issuance, in connection with the listing of the Shares on the Exchange, and (2)&nbsp;such as may be required (and as to
which we express no opinion) under applicable state securities laws and regulations or from FINRA in connection with the offer or sale of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11 The statements in the Basic Prospectus <B>[Add the following if opinion is delivered in connection with a Terms Agreement&#151;</B> and the
General Disclosure Package (as defined below)<B>]</B> under the headings &#147;Description of Common Stock&#148; and &#147;Plan of Distribution,&#148; in the Prospectus Supplement under the heading &#147;Plan of Distribution&#148; and in the
Registration Statement in Item 15, in each case insofar as the statements purport to describe the provisions of documents and laws referred to therein, are accurate in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12 The Company is not, and immediately upon receipt of payment for the Shares will not be, an &#147;investment company&#148; required to be
registered under the Investment Company Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13 Without independent verification of the factual accuracy, completeness or fairness of any
statements made in the Registration Statement and the Prospectus, each of the Registration Statement and Prospectus (except for the financial statements and financial schedules and other financial information included therein, as to which we express
no opinion), appears on its face to be appropriately responsive in all material respects to the requirements of the Act and the applicable rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Confirmations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1 We confirm to you that
to our knowledge, except as described in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus <B>[Add the following if opinion is delivered in connection with a Terms Agreement&#151;</B> and the General Disclosure
Package (as defined below)<B>]</B>, there is not pending or threatened in writing any action, suit or proceeding to which the Company or any of its consolidated subsidiaries is a party, or to which the property of the Company or any of its
consolidated subsidiaries is subject, before or brought by any court or governmental agency or body that, according to the <FONT STYLE="white-space:nowrap">Back-Up</FONT> Certificate, would reasonably be expected to result in a Material Adverse
Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2 We have participated in conferences with officers and other representatives of the Company, representatives of the Agents and
representatives of the independent auditors of the Company at which the contents of the Registration Statement <B>[Add the following if opinion is delivered in connection with a Terms Agreement&#151;</B>, the General Disclosure Package<B>] </B>and
the Prospectus and any amendments or supplements thereto were discussed. Although we assume no responsibility for the factual accuracy, completeness or fairness of any statements (other than as set forth in paragraph&nbsp;11 above, subject to the
assumptions, exclusions and qualifications set forth in this opinion) made in (i)&nbsp;the Registration Statement or any amendment thereto, (ii) <B>[Add the following if opinion is delivered in connection with a Terms Agreement&#151; </B>the General
Disclosure Package or any amendment or supplement thereto, (iii)<B>]</B> the Prospectus or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amendment or supplement thereto, or (iii)&nbsp;the documents incorporated by reference in the Prospectus or any further amendment or supplement thereto, nothing has come to our attention that
causes us to believe that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Registration Statement, at the time the Registration Statement became effective (except
for the financial statements and financial schedules and other financial or accounting information included therein or omitted therefrom and for management&#146;s report on the Company&#146;s internal control over financial reporting and the
auditor&#146;s report on the effectiveness of the Company&#146;s internal control over financial reporting included therein and the Statement of Eligibility of the Trustee on Form <FONT STYLE="white-space:nowrap">T-1</FONT> under the Trust Indenture
Act, as to which we make no statement), contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading, or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <B>[Add the following if opinion is being delivered in connection with a Terms Agreement&#151; ]</B> the Prospectus, the
information set forth under the caption &#147;Time of sale information&#148; in the Schedule to the Subject Agreement and the information set forth in any Permitted Free Writing Prospectuses, considered together (collectively, the &#147;General
Disclosure Package&#148;), as of <B>[Insert time of sale appearing in the Schedule to the Terms Agreement]</B> (except for the financial statements and financial schedules and other financial or accounting information included therein or omitted
therefrom and for management&#146;s report on the Company&#146;s internal control over financial reporting and the auditor&#146;s report on the effectiveness of the Company&#146;s internal control over financial reporting included therein, as to
which we make no statement), contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or <B></B>
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the Prospectus or any amendment or supplement thereto, as of its date <B>[Add the following if opinion is delivered in
connection with a Terms Agreement&#151; </B>, as of the date of the applicable Terms Agreement<B>] </B>or as amended and supplemented, if applicable, as<B> </B>of the date hereof (except for the financial statements and financial schedules and other
financial or accounting information included therein or omitted therefrom and for management&#146;s report on the Company&#146;s internal control over financial reporting and the auditor&#146;s report on the effectiveness of the Company&#146;s
internal control over financial reporting included therein, as to which we make no statement), contained or contains any untrue statement of a material fact or omitted or omits to state a material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE 1 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PERMITTED FREE WRITING PROSPECTUSES </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE 2 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MATERIAL COURT ORDERS </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d349058dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g349058g40n93.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">


<IMG SRC="g349058g72v42.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December&nbsp;14, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alliant
Energy Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4902 N. Biltmore Lane </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Madison, Wisconsin
53718 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Re: Alliant Energy Corporation Distribution Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel
to Alliant Energy Corporation, a Wisconsin corporation (the &#147;<B><I>Company</I></B>&#148;), in connection with the issuance and sale, from time to time, of shares of common stock of the Company, $0.01 par value per share, having an aggregate
sale price of up to $225,000,000 (the &#147;<B><I>Shares</I></B>&#148;), pursuant to the Distribution Agreement, dated December&nbsp;14, 2022 (the &#147;<B><I>Distribution Agreement</I></B>&#148;), among the Company and Barclays Capital Inc., Mizuho
Securities USA LLC and Wells Fargo Securities, LLC. The Shares will be issued pursuant to the Company&#146;s registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-251353),</FONT> as filed with the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) on December&nbsp;15, 2020 (the &#147;<B><I>Registration Statement</I></B>&#148;) under the
Securities Act of 1933, as amended (the &#147;<B><I>Securities Act</I></B>&#148;) and the prospectus dated December&nbsp;15, 2020 filed as part of the Registration Statement and the related prospectus supplement dated December&nbsp;14, 2022
(collectively, the &#147;<B><I>Prospectus</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our capacity as counsel to the Company, we have examined or are otherwise
familiar with (i)&nbsp;the Company&#146;s Restated Articles of Incorporation, as amended; (ii)&nbsp;the Company&#146;s Amended and Restated Bylaws; (iii)&nbsp;the Registration Statement; (iv)&nbsp;the Prospectus; (v)&nbsp;such of the corporate
proceedings as have occurred prior to or as of the date hereof; and (vi)&nbsp;such other documents, records and instruments as we have deemed necessary for the purposes of this opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As to matters of fact material to the opinions expressed herein, we have relied on (a)&nbsp;information in public authority documents (and all
opinions based on public authority documents are as of the date of such public authority documents and not as of the date of this opinion letter), and (b)&nbsp;information provided in certificates of officers of the Company. We have not
independently verified the facts so relied on. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In such examination, we have assumed the following without investigation: (i)&nbsp;the
authenticity of original documents and the genuineness of all signatures; (ii)&nbsp;the conformity to the originals of all documents submitted to us as copies; and (iii)&nbsp;the truth, accuracy and completeness of the information, representations
and warranties contained in the records, documents, instruments and certificates we have reviewed. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alliant Energy Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December&nbsp;14, 2022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on and subject to the foregoing, we are of the opinion that the Shares, when issued,
sold and delivered by the Company in the manner and for the consideration stated in the Distribution Agreement and the Prospectus, will be validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing opinions are subject to the following exclusions and qualifications: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinions are as of the date hereof and we have no responsibility to update this opinion for events and
circumstances occurring after the date hereof or as to facts relating to prior events that are subsequently brought to our attention. This opinion is limited to the laws, including the rules and regulations, as in effect on the date hereof, and we
disavow any undertaking to advise you of any changes in law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We express no opinion as to enforceability of any right or obligation to the extent such right and obligation
is subject to and limited by (i)&nbsp;the effect of bankruptcy, insolvency, reorganization, receivership, conservatorship, arrangement, moratorium, fraudulent transfer or other laws affecting or relating to the rights of creditors generally;
(ii)&nbsp;rules governing the availability of specific performance, injunctive relief or other equitable remedies and general principles of equity, regardless of whether arising prior to, or after, the date hereof or considered in a proceeding in
equity or at law; or (iii)&nbsp;the effect of federal and state securities laws and principles of public policy on the rights of indemnity and contribution. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We do not express any opinions herein concerning any laws other than the laws in their current forms of the
States of New York and Wisconsin and the federal securities laws of the United States of America, and we express no opinion with respect to the laws of any other jurisdiction and expressly disclaim responsibility for advising you as to the effect,
if any, that the laws of any other jurisdiction may have on the opinions set forth herein. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the
filing of this opinion as Exhibit 5.1 to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated December&nbsp;14, 2022, incorporated by reference into the Registration Statement, and to the reference to our firm
in the Prospectus under the heading &#147;Legal Matters.&#148; In giving such consent, we do not thereby concede that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the related rules and
regulations of the Commission thereunder. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ PERKINS COIE LLP</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>lnt-20221214.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 70.0.8 -->
<!-- Creation date: 12/14/2022 3:22:04 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:lnt="http://www.alliantenergy.com/20221214"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.alliantenergy.com/20221214"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lnt-20221214_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lnt-20221214_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>lnt-20221214_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 70.0.8 -->
<!-- Creation date: 12/14/2022 3:22:04 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lnt-20221214_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 70.0.8 -->
<!-- Creation date: 12/14/2022 3:22:04 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="lnt-20221214.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="30.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g349058g40n93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g349058g40n93.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?J0PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g349058g72v42.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g349058g72v42.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?J0PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M=0#7K6Z6\S(C;'F &Q6QG!YSTQSC%,1-/=0VJ;YG"1C@N>@.0 #^= $H922
MP)'4 ]*0&?-K,$,/FB&:1<R9V <*APS<GH/S/I3 8VN0K(R+;SLQ8K%@+^^(
M;:=O/&#ZXH OVMPEW;1SQ@A7&0&&"/8T@): "@ H *!A0 4 % !0 4 % !0
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MR1MB==RGRA\N#G//WAT]Z +-AJ0OG=?(>+"K(A8@[T;.#QTZ'B@"]2&% !0
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M#I$JL#V( S2 L4#"@!:8@H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
F * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629089136064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 14,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALLIANT ENERGY CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">WI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-9894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">39-1380265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4902 N. Biltmore Lane<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Madison<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">53718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">458-3311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LNT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000352541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>d349058d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lnt-20221214.xsd" xlink:type="simple"/>
    <context id="duration_2022-12-14_to_2022-12-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000352541</identifier>
        </entity>
        <period>
            <startDate>2022-12-14</startDate>
            <endDate>2022-12-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-12-14_to_2022-12-14"
      id="Hidden_dei_EntityCentralIndexKey_duration_2022-12-14_to_2022-12-14">0000352541</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2022-12-14_to_2022-12-14"
      id="Hidden_dei_AmendmentFlag_duration_2022-12-14_to_2022-12-14">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2022-12-14_to_2022-12-14">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-12-14_to_2022-12-14">2022-12-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-12-14_to_2022-12-14">ALLIANT ENERGY CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-12-14_to_2022-12-14">WI</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-12-14_to_2022-12-14">1-9894</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-12-14_to_2022-12-14">39-1380265</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-12-14_to_2022-12-14">4902 N. Biltmore Lane</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-12-14_to_2022-12-14">Madison</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-12-14_to_2022-12-14">WI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-12-14_to_2022-12-14">53718</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-12-14_to_2022-12-14">608</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-12-14_to_2022-12-14">458-3311</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-12-14_to_2022-12-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-12-14_to_2022-12-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-12-14_to_2022-12-14">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-12-14_to_2022-12-14">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-12-14_to_2022-12-14">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-12-14_to_2022-12-14">LNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-12-14_to_2022-12-14">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-12-14_to_2022-12-14">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M@)&.5?1:A4E,!   AQ   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R5
MF&]SXC80QK^*QNUTVIDD_H,AD (SA"17Y@BA@5ZF[?2%L 5H8DL^60[AVW=E
MP"9W9LWE16S9TN.?=U>/++H;J5[3-6.:O,>12'O66NODQK;38,UBFE[)A FX
MLY0JIAJ::F6GB6(TS ?%D>TY3LN.*1=6OYM?FZI^5V8ZXH)-%4FS.*9J>\LB
MN>E9KG6X\,Q7:VTNV/UN0E=LQO1?R51!RRY40AXSD7(IB&++GC5P;VX]WPS(
M>WSA;),>G1/S*@LI7TUC%/8LQQ"QB 7:2% XO+$ABR*C!!Q?]Z)6\4PS\/C\
MH/Z0OSR\S(*F;"BC%Q[J=<]J6R1D2YI%^EEN_F#[%VH:O4!&:?Z?;'9]?=\B
M099J&>\' T',Q>Y(W_>!.!K0<$X,\/8#O)Q[]Z"<\HYJVN\JN2'*] 8U<Y*_
M:CX:X+@P69EI!7<YC-/].QED$&1-J C)O=!<;\E([+(-4>O:&AYBNMK!7O!V
M)^B=$F3!%7']"^(YGO=QN UL!:!7 'JY7N.$WE"^,47^'2Q2K2"%_U41[13\
M:@53US=I0@/6LZ!P4Z;>F-7_Y2>WY?R.\#4*O@:F7@9PODU8%1P^O'WY&8'P
M"PC_/(@I4UR:1(8$RJ&2IT;ID+ZZ_#4+M"8JN*^I9[;B)H/ .*%Q)1BN,QB/
M1X/)G-Q/[I\__4V&3\]3A*Y5T+7.H1N)0*I$JKSF+\A,0^R(5&0H,Z'5%HYA
M)3(N_C)""*\+PNMS"!]XQ,@DBQ=,58'@&NYEI]WQ$9AV =,^!V9.W\DHA'KC
M2Q[D,4/0<,5&Y])MM!VOU43P.@5>YQR\01C"/$\O#B=D#/W(DZA,(:[H=QR/
M3*[(+8]T+!4C8_JMS =2URE]U_DAUJ%I0<G-Y:;:=7&Y1QKR]%N__HAVM"2X
M/X163(>IDF]<!)5QK-%$YX);+@8NZN7?H4UEJFE$_N')R3E:H]AL7+MMC*U<
M"%S<RO,,#N#3Z#0*+M!R4)!R,7!Q#Q_+ &(R74N!64:-B-]L7S8:KHL1E6N
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MHV 2I@/<7TJI#PVS>2U^>^C_#U!+ P04    " " D8Y5GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( ("1CE4<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L)
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " " D8Y5!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M ("1CE6C+NO@[0   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( ("1CE697)PC$ 8  )PG   3
M  "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ @)&.5?1:
MA4E,!   AQ   !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( ("1CE6?H!OPL0(  .(,   -
M  "  8X,  !X;"]S='EL97,N>&UL4$L! A0#%     @ @)&.59>*NQS
M$P(   L              ( !:@\  %]R96QS+RYR96QS4$L! A0#%     @
M@)&.51PX9>H_ 0  / (   \              ( !4Q   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( ("1CE4D'INBK0   /@!   :              "
M ;\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ("1
MCE5ED'F2&0$  ,\#   3              "  :02  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  .X3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d349058d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d349058d8k.htm">d349058d8k.htm</File>
    <File>d349058dex11.htm</File>
    <File>d349058dex51.htm</File>
    <File>lnt-20221214.xsd</File>
    <File>lnt-20221214_lab.xml</File>
    <File>lnt-20221214_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d349058d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d349058d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lnt-20221214_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lnt-20221214_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lnt-20221214.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lnt",
   "nsuri": "http://www.alliantenergy.com/20221214",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d349058d8k.htm",
      "contextRef": "duration_2022-12-14_to_2022-12-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d349058d8k.htm",
      "contextRef": "duration_2022-12-14_to_2022-12-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.alliantenergy.com//20221214/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-22-304962-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-304962-xbrl.zip
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M^;;<+9/.*/3%A,D77Y)I6TJN9A;'&C[X'V'C7Q6%FJ#F:3"T6=TI@&P<_N
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MI11?%W:\')P!N,3=>H.?20=,N)ZD$[>N&N=5.W#BN:0VT>0H*!36I4?>^T(
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MH1*34#A]W/;-K$\4&7<E@ZVV3W1QA.7U?;5TERXH%"K-CA@DH]11"0QZL:_
MC*<N^=_H>;S7B"+IJWY#!8V/Z<%/FXLZ>ZHJB"]P,8Z'?.CQD#=3AH/Z;F@]
M@'3W=]ZNE)Q8,HH")5U?;K<>KGW3=Q9$.!9"&X7.=@2A354()\*#^(J! :JN
MM%I(;YV1P5L0^![-C.8E>L08O:<".?PT17]R+8O3&/\,A;F#'XD=;"%%"2J>
M@>V<@*B;F=&X$*T]R&)_N+VYDFT1CXUM"7C%)<>%;.)@UG=C==4TROB!N(L^
M;.:G'LP[GM+5K )]@MKS_L"5]6G!$#[%YM"I2M:?)>$YN$2,00TDCE"LF-IU
M95G!82I7LC!D":T74G\37ON5PZQE_S"^I^7P"=4;H0=E+T.@09\(40HS!%TV
M,IL-"*^8GY-D""QI[Y#P=@4&WNNR[X4<S=E$6;,&1U 8RW!?NQ*. >+L8(NQ
MO$9,S25\MVREMA 4 +S2E;D8Q$ZH!0(A_< I-TH<S)5T9S@L9_ZP6?&YANL>
M? G773M<YZVWF#>EZ(96^Y!+94AY$9G[= ^=D0\R#DV?D*AIMNE@^ /ZE8%[
M%1=%D?L[.1@&81QKFQ&/8QJ3U"M55(',W[ $4RUJZ^X7)56TXF^(3Z-X5S)1
MEE LN5_@!]&3)$04QF60TH."$;C.*/L%?]NTEXRS6BYN!;\Z!1'X;V5=RB++
M1J4P>?-F?JX:/K!./:GJ4 %']3&H?F^+0+Z)^L27Q:6U?>/J'=P3C=\HZB'$
M1 Y#2U%@9I?%IZ#."+=W4;6EWWAD$C75/1(FQ78 H)4<;E'D>@S</!QF?AU\
MD!25?CTZMZ"T)@=+N'P]>=QIA&N@@J(G@(J.I'^B,OK(%<;8BDEKQ@6(5[U,
M,M=<:_/\U!.IP!)+<<J2U# :\T]+N"@5'?PW+9+M^-(PMEH)'R^?HLOZ.TB%
M>5M<8#8*/HZR S8#'!6J_\L.W?E^^OO)DP#DTKK0(NL[5U7JICN@BD''=QMN
M4?H#K.7L,O.=/"P\5P5%F(IIL^G!J/G^SIVLN+VZG1UJHY/L"=5'PLW0?@5P
MSIG8=H122N&7/!DBO>U&,-BY(B3)&,1P,MQ46+GVTE4+<&3?GQ'=OL)68KHF
M&%+NM&V14N?XR%3#D7$27E='%31"[!0=X0!%?#.UE/GUO1$M7AP!_.91C@PI
M9*D.?;#H&LP=1-KCR-S8KG#\2)6@ $/8($";=U$) YN_FI+(&6I>APE.^ 7L
M$DC "9[ \HP\2V)5H.^9*2="B>,QJQ$ZA<#P3\4A4\\BNH(\B+@HPMF@[JQN
M&9NR I>CC?"\LI[K+AI=%!JXV;)AKA<5U@SF,L/C*+5.M";+JCPO_<DHWY6K
M-86P#56SO2=!H?V=8S  #H^)^6H/1X\R> 36(&Z^2IF;DY'XG!+/(4:?3C5?
MGL;,R9=0A5$D'458>K0EAM2D6QL9/YY3),0+SH%"5@\\FN3B4<:8!("?M?C,
M?VSFIRJS2:K2=&YGOPX]TY *P?!YJRWN",O!5&$*[?7992=55(8+  UY;%2E
M&3ZSF]_<C=@,>#E G2D;*7SV:#>;>6MM74\L/Q ',+;99JE)IJUX4VOS\!B]
MBGGZYK\-%1'(5HT_['DJCVRS%8=AG2)D!QSY6ADAP!TO/$,(O.8Q2#Q,+9]F
M+VZ_O)V%6KUK0'(0!<(N\KJ48!^(BO_UX+SOMF'S[F_'YBW^A-"\PVI0RG^!
MK02ZI$[<(X.033<!"XLU;XB./RH(+Q)TA21RR>\W@G9@=,AM\:K5-@M*$MA%
MI6(Y)>(QW15$5OW\"Y+(48T2O^;0%<NC238O9TN0"93[:N)27M151"K0+$N*
MR;8E#N:(0!C>G,6_;+K.YX6#(.%@4-K\AX8SI'P=V"FV*'*H6 :E6F%-V,AJ
MCF!Y/\,(X,,O$4"_D/(K_/+WQ_>N;.Q5%:?9$MWR$B?/&M&:OFY"H[UI!\$J
M/MEB!E/,W>5+1VX!F3]DW+BZ7^-LE_+9>'A\V4A&P#";1>)N#-(F <Z)S"3T
MYV#D82WA2#6\T\4>;#$YB-Z1[QZ&S]CV;;.\ 9/_5 C#AB986+9-IR(I7\#>
M"P(@5V,54.*V>.5LV9$&S31JK&,-(U8&$JA>6"],@NB>VUC.R6 ;'(NRE(!2
M"J: J1C+/&J!A+EHF[BWHPF@;8S>8J2=FN^F'KX)QIO2W*,^1HBM\)X#[<-[
MTKQ'$4W?7H%ALSY]?A4J^#S1\\$)@,$-/5%ZG/3D=:OPM;YL+CS  :!^.F*A
M^+7FXOI<#!;) A*O=S4G(@N[)"X&HBZ+H[(?GA=JD]Y1G1V+,Z4+R@-":5,]
M-).OV@9'(;T8;V@:.^(O S>JPG>ZR)LD6((_#.F&74IA2.GMY<!HI(ZJB/)H
M_ :/-LQ1QDU41V. C*TDJDD;TQ7&4 W11KLSI,WXXB.]AX]T]B?UD6(LA"'Y
ML=W)8C\F'7NDJY6S4^7I)7,"DRN0P(4R-(Z1JWC?[8*YT,LHQ(+P&$FM>\3W
M:WH9P16$UY9["^P#^RT9U.MB+*"TEQFSY'1]NS'87-)YP5S#J7J9$Y#KIB*O
M_BFXMO81CC]J[B".2M]2U<F"RMS7,07J<$I-;K(U\;WIQFO[$#BWN^#.=5/?
MXD:!"G@V67/J#>3IJ(:#':%+'QXT<=ZQOKDCG5$67:GJE@ \KK+&QXIY7)B6
MK.MF0UD$=%W+@KKC4HD7[/^F-)V3I.B+0#8-#%+@EH<!-[E\'S0O/S9NV.#9
MB[4=ER,GH2R4!!?OWL_.L+#<]+OR?P]4:$4-M[+_VE"U DSH%56*[]\%^OC.
MK?_2_1%@?%TC2"WYH,G!]D?]W36&CM713]QP#&50N" X8R979?JN9ED)%T^J
MD571J9[RQNS*<>PWK?QKI.$64O3:RHGD?MWF>KRMQ;M[M#WZ -YE+(QG2P09
M\\*BL([;1-[%-I&*::K&HEVA[+"^BA+*82R+PON%Y-09Y!%Q5,F:.[)(?Y[A
M$"57=LOQ!W^'J[SH-^:PI'0+=R=UO,?25]/ZN1'EU*'T+9TUZTM&UQ"LS$ME
M%KC85?W)!@8"7[GJ/?K6G_WP3 \;M-")]:>;F>8XQVEQ18?.]OM<\6;??(DV
M?2AY,#F@(PS_AD6P+<Y].%4 T,7R$AU6<=U%PEX4G9[(N2.T2M_10QO41I2K
M?@J,GC]*)=E&GU.R5+ 3X 7/;RV;YBTWU.B+C'L/6%#FY.!?FT;\YB-'IA #
M&-R8KG#AHJZDW !).B1T2F#O\'B<%2QF!*4)Q$3.)F'0LX/[9((-,:5H!EY?
M=#7[DI)RG06 N' $_<1?='4&^N' I-O49ERXOV?E$BL^'"OW$)8;Y/]&(*_C
M:%G>%L;7TK_EUQYIBTG"I?#,3"^'10UY]A Q:/C=AXCL4&US^$1;M2 3YUSJ
MB3P#;[-&<;JIJ_XR*!V)"D>PM!\._2Y^7:P=T2X7;KNDI6EXM/<Y1JX@C_@Y
MG\I$T+0*'[:'S6NT0*)[-W=6 X<&,RR,;X8+!$N2!_@4;<?%6% BA0WZ_P0.
M^^7U#@*:M5O/@7&[,&H#$F5@:I"-X@]TZ[ -QCXUE(XA4W8:+9"L@DT9MSMW
M K6VHB8""W=@WNYAV08/,^<E86*:KL@X%T2Q+4%0LN 3@'N2+GP+A'T'_-TC
MYOU66O1\U&H#9BIB?/>U#MHY[3P%%5;1@JZY-*6B-'D1 >(TR<''>CGGK:9,
M631Q=2 VG$UQ6@S8$S2D[C4@Z9-UGY;=M8KHG0V;L]Q/WU>0@YSHY,SD3$A3
M#/>IZ>8R5V!,5) =PQE<#)F;(#-^@J,243<*MF]O(#WRQQ%&H;%JY33=KIB-
M_[IO$=8>\;N/Q95<_3T;[Y7M#BMAE3B6DD=.39=OB:YL.)50M==L^K0'Y70>
M'@BE0NBY+'Y6;F7XH/.!%[DP[#D2(#:D"Z>$.H0_U64?U)S!1F#9?N>2%"D.
MGK%OC[2RWD;7P#F N/]<4OZ/D.Z074>A=^8]_;0$$+NUS?3R%C%$.,VPFRA"
M-C%S>SBZ*Z81R1KEN)AG2(F<Z$2GSQW=X96BSO70>60^?M,AE_FQ(Z0EC&MV
M#&KVGB+BD?,]8:ZHM4]:E!1RD[0)'86N;YJYSZ+Y?K^1742"-8;5N4X07MF:
M8G3RNIOE@$DFS-&]MWB\,H/Y/6(P?Q4E%2<'OX=9Q9.QK"+SF5OEXQ*402&X
M3^^*<L(URP/QJ/XCO2)H<FG:5-H. JYF+J1[]0.9E6#7Q#W*//@37*-^4&J#
M*X0#2/(Y/[+D^3M>+^"'S@:%NF&>'!]Y;I^H T"L=H""C!%=]PZ+(QQ1\.TH
MYR:,_^=VS),#*BB_-2PHW_HZ--*.;/:1IBZLZ/!ALV-"'0!O'28%PZ,6)P;S
M#]GJ_?U9\LM2FD *UI9O  JI#5&N[AF9>WWKGHKE &[+%V=$OE4H;5VKL@V6
MW8'>!HE2+A>A)'/!:0'$#I"S!(^]?^>!WEU$^K)QJ(\EZV):SHC&@DPYQ#2C
M9>()1&!?07=<ED7;14AE?SVQE!G&TZRQ_1N"8AD]K3%66;5QJ9ZSO#6-W\0.
M?>G4YT\XBM^E2=7G&I?\]DM<\MIUL.9PN$H;L>R&/0#!&P2#!?G&*!C#X?:B
MUQ"(0=Q46O].21R,YNO)10M.CKIKFQ.IP9R^8%AY;-&CQ%YR-2U]ZEDL'#0O
M+"3=,D1XMAL;F7<39RM$RBI"18R?X:@(Z4$UB\-WX <E_6S3W*;OX9WCP].C
MP[MQW\.&,$.& L?<[4A:X7Q3XLJ'26/CC5+W+E4Z*PM?T /ZZK1"8\Y[2?'[
M(CL/7O+IW4YNP>?(3JC[(7UFBT4[D+^'/D,UC.1P:-Q]=DY, TI[AI!E5E:]
MQO*P'QI9+)Q>#[^9K,H1#,#(N;AWY_'A@@Z&URH<O\$*6'I50M?GVQ9 72\S
M? ZB@PE?AM-QYY[\3L)?PB]&:OC0QT$B*T$.Z#P-^CO0[WX^ O6JN!9.7P7_
M3KZ'&DQ3D!ZT)7@X[:8TAYWPJ6X(&/ZG$"C%IAK^W. #KL1'BMEZ)8@@7!=Y
MQDJFU4N+5W(T?+9:/TNJO.J6)<4#PL;*1J#6HF[-#A (:[ !5!6LJ  &U0V5
M-E>EZJ/")W%"R#OD$JI*'AF7-](=D%]<<9U[\X3MZQYPE+$EDUY?FCDNL"-I
M62),4(_0K&IGFU4G#+\L0)VG<)E=8'\U1'KF@_UY,X1Z6G>J8E87"EU@CJFT
M+58\NXU.D+>.CTPCHK_S^F#<PS9[JLA@#+*S]T3U39Q()^!U@R;:I;0],\IJ
ML6EKS/T/VC&;;J.B+47DE.\(2[.\=+9VM346<!@?6SVF1]$DQC^X,Q:@R!>)
M<-+9MK.4.)P3'P%!QWH-9K.+0&+N?=%3\1\\O%B?&=TZ*];T%;;[7RXI,)L]
M-50\8N7+D\SD7KO+=0,Q:(*@R]0?%QWH8C,RU?')P1*$B-N7&SMH3$6@< $+
MH":/A;_)D2#],AE8@_VEF!1_?$2?W;T?6CBYL:V()*J1[^_6)FI\<H4G7I@5
MM\)>;UV20=MRN0WF#@S+,*O.UV%>(-*WPOU#C\XQHB[A&VU3BY=']!@B#6?-
M6BK&*9$IR^EJ0D12:#SRF7L0RN4B^[G +U*4_$23_CBM5R6<U?(<85-,].#5
M ?=ZU=^K,C^<@<?/U@BJ<)^*?_KSR:L@.I#B>IT<!+%54_^YAV/^YK9ZYI_:
M0J0+,^+6^D.12SP,4Y>,,R1S3<TL M&C_ =_ D^TF)@^[4)GN+24A@P\E&R/
MR5?0'Y6[N94R'X%?P"UH%?T8X?^$=H!N84!!((>7@A'=#(27KX*N8=TR5&PE
MX1[%OLH]0S1I.C&UC+*_Q+)&+U4E#,L5/T@HK?_NC%4H]4#N;D8BVS)3;E.$
MX54U259:(J5FPE\WX%BVZ@$2&K_DEJD"QA<;UXH%A_!<6V'@4;!8F$3B32\J
MS5P=):XTWV +U%*,)&W_1F68%CSGBR!]E!WMI9WGD%\M1,K\$OHW=4.4 BS$
M5\,-;M8JJ6V/9=/G9/?+C,$W.6 RBO<S^;C-\H>Q^70K\\\V^O3=E^C3M:-/
M.\W\V)8/4\AR:9W(M+77#M-OQ&?7^#2^1%CVO$/HE%+D1$1Y)2%EJ68.G#&4
M%.AQ.,[)K+]HG(3NL-3Z2D[%EHBM&2$1+F3;O @%NNWE3>QP(9RK=@/!H X'
M,,]4;@R239CK,8P6S';E$BIQ;*9D4]L7C8W4J2"H.*QCE=>YTD6U[*JZ0G0P
MEJZ3_&-\7-\6SJRMZO.RHWSVMA+.@MM+O\>X.7&G%-S)8ER91.+]-P&]F1YE
M)WTP,$$!;DMR%.$W"%[1=!RJK?NA=TJ+'J#V*-JE@4&'IU*$V&%Q='C/!N9\
MH5(4D\$H#%P<>'!_RX<$W=_ST*+A)H )/RI\/W%W'S] &)<,(21_;5H._1)V
M4L7!D<G^1EFEB"ZV$ ;,#NTBODL76$B P7GL.H\8&;3IT%QNASDQD#,VO&VS
M8C< 3T(Z19M,X[3Q[B*WR8&HDERP)DSZ@W7]_%.>^<XIVDGF,K+SIY>>60__
MRHOI]T06[S#-^NN"OBQ@Y^_SB&T40Q&_$)QVI8LRB!S+A)**06P%*1C G*/\
MJGJ!7+,[PQE/@[BVT(4M'/(#MA4UVYEJT#HZ9&MZO-Z@6-TT-$N0-FO(B(\]
MZ.&R=-&UX7:,WH=[]\(PR%&F*3,QHGU:9L@8?=V7PB6,7^IV$[/@>U@3IM9\
M9!3Q@NHED#T-B/K$B#@,W;PQ0T;*?P9$IPCX"6.86VFTXO2A>'T54F:UL3*D
M3CSB4]J:;Q2.<:WWKK7SIL<P@^B"8.ZHLNZY1E)ERRFS*"V$>^^UY=8+1U7*
M 4%5BG&FDQJ4NXQ*GBW+T[)VX$CNX)6]+<NUB[^GZ _(WJU+=K);,4"FC"7N
M?%V<P\!4YT<RS X4:SY8!K ?D$W/+0;R2C)KGN..\T#2D31J?*Y'>E$$QPL7
M0R@OQ?ASX=3$XKD43#>DHLNMY)TZ+J;M^YV[Z76:)PW/2F30&%WQ*$PAL#"=
M5QV24U:\7B.C.'YX'ZLVL.SW5$S4:%#DO"!S*Y/NCVND=-PLWRX&RX0@)(=R
MJR2,P]6=FPR-8K"TX?I<B+9ANXI9>2B#SO!#Y1#E(T4F5VQJ[O/.9/HX?0PY
M21JC)+8DA!/PW$JCA*KR:H<*L$;?4)@1*!3A''5#[;J,O3!5PEYBYW5%S[Y+
M=:C(N6=!<3F\EXO2T]R8)> <:=1R,>T#F>/PX)L8,?:YQIS@#G\).GTX/F,\
MV<^M:_94NP.$WJ7/,\.1]-S!J&!":4_TMD[<?P)X1>@24MTCY=E@B/.(=(:N
M4L\T&SX0M#5FG\?)-8V[AU;%Y"!E5NP+^,@^'[P'GA?.PZS%-R%4EG8R@&%0
MR5823L\8 X1[<<>IJILMB:"Q"MCC-)C$-EB7-,+&6(+9\Q_/GE!(:MMN8[UQ
M*Q2:5,D_ZT?/93XY2/:,9%2S6:1*FE)R<^F96I<.?.>3+MC!D3DCHKBJ(WJ(
MGVO3=O+<D<4A1W$,<*M$!CO6;7(PGMH:&6%T?[;C<*T?=A.<UWB\04-C4US,
M?%L6C\E!DL8C(D>C9>PC_@_<HFI>%:V60; L8\L%;ECI\6@6HK1M.ZXBLO9=
M\DQB&2!#JM9Y9I.#H4#FC'"2X82Z-I@T\146IG>'LJ/XTZQ0SL?!^\(-P(5"
M?@T^[!V;W,3(C')0:+Y!X()+CP4!^PP-R[[-V-00$TX6O<J8[WB-MF#R:'A,
ML'/L$[D)\![+EOMB4JD(3IEK9-GJ)\8GK%GS;2Y^/CEY&;"@K47)UDQ=J75\
M3/@G/B2B/NT49+,U98/"!AQ3JO3O9F?E',WU@&EAJ]@4KKKD"4IH]$19/$YJ
MD%G?JLADX(1+*>=C!]*1.)"&VZRHZU#ZLR$L()[[3B-@[RN56)!XXMT9QJ![
MD^SWIPEM*$78%++)P^K-PD47B\V\&J,APBE?2\KPXK,U%3+ X,.QH&\68<V%
M8+#X$#(N!7LBXAS$$BBP1=;<'?1Q@<:A$7=+MZRK,&*D^)QD1-.F>=N96-#5
M5005O\0K:]]DXD\NT#AS\)) Z4O!JJPXM43^U&KE!C3YXBA[70E:)L#.LW+A
M((;P@=L;KVQY'\(E2 8:RT0CT%"HY4')8EN&\!SB7^7=E3'.BG75T_G W@.'
M-M[="0AK$?8G$+"TIS&,<G"B,W']ZIZ"C4$+-YCMU_!=C+PTER6*I+I<@#.R
M7DH"Z&I:/U$ZJ5_FX2)TM;/:+FK%&V_4Y&"KE, 8^EJ@B3 J+*8D3Q73TM*#
MHGR'A?(,DFC60H\KM*U$4D%K;'HDG2*46K>0K&\^(Q8;M9L#,MU"Q$=M[=/2
M6QNV04ZX5#0(4"PP_*>4WLL8&*RXL7F%U!HDNCA13P/#G=VUZEM%\Q$3%X)Y
M<8M;5+?9LJE/^8=Y.>VS0[D81-8#;A=ARZRMO/:MXLS?*^F:!6*6$7 SY!JD
M%=(XW)&M]/4WBFY3W7A-7,SQ*)3Q[=+0?6Y$L2X7WM[<LTKAT#7X5RQ0^5SC
M.I"^F=.=1"%1E]P& ,S CD(OVB?LLPW?'7\)WUT;,P:F.RDK% )Q+\0]68G&
MA(S".AA]"R9&U9DR@RWW*Z=:'S).^78Y/65 G&1FGC?+<TJ3N50&:N2Q"_A!
M;\Y[S&_(__D/'?&)C/@9X5UL>?_DP-3WJ]!1\QVDCNDRVO$PR3H==M63[9+=
M'9U\'J(6&E_HLG7GV (J6K,+J03,WGM .9DMF\"P+L<SX$4^1Q"]_NEL\8!J
MMSP;BF^GL-":,;4M"D1Y6Q%I I*387!-\C8<"DMW$X6/=@XI'QA7-X$*.ST:
MY)YHZL3)(FUC)48"U_P<A-%\B9010JA"V&FU]L.X*9*\N(Q:+]FIW['_..R@
M>IR=^S*2EQ"/#QF[3 ;#!'A@3N094Q4S@U=)#A@N'W;@*5M'_F'8\O"O7EDF
MH/UQT4\3M,-!9XUEX5Y2[]&@.!C^2DOHDKV\5*A 0)P'2T:L<7)?S9AYQ6&T
MIUC?Y8AM%4K$]_$/L!"[>3736*@!K\N;9\[S\(@"E55!^IDN,UINW5FU)@L*
M_B1945EG[;OB5CFX['+=&+Z GP(+9;E!@$"#R\OCX4>(SS@Y".?FNSD*')_B
MSR/B\ :\OC-I8,*2&KO.T@)31%Z$U*5DSB/M<JB=K\DB1<2KP1?MK/XQR(!;
M=^XZ@K[%'M]T-4;\_=>W_N?(48QW2HH"!^#9N[-J6O7"*'=\^WC$P(\I ?<@
M>@P9 ?7M&O!$FHZ,D=Y/RUF)U$O"&G.<9W?OW#VV3"Y^F3UA4;HU]:#%@]FL
MU^XI!LI,>;VPO&OH.)JG@!=H%%/0-I;.2/J%[R]@46%S<3U\:UD5@H^8R4%+
MR]] 3(CJ<5&)/)3#IL@G*8_!&?H4 GDH0'MOUNPO)E7@OJ^@Q"#/#4K*[#T$
MY:-D4&B0'!V)17'IGLYZT[LQN"@.&I=23NQOZNCQ5R,U)GW#C=33;ZOM_<O-
M;^TX?*1B&*W:9TAHG>)NQJ!(F#G!HRBULT0I)2:?Q&7\U'-$V/6G!1+*K85T
M!3GG2JG\L\S%VCNB?+?FI (V[-E'V?U"8+[]MH%B6^G9&C(#>-]YU2P-!!AM
M,+1HN%$LAE2TNZJV%,I\DY.S9CEGRKW4$+:M^(=;%,H0<)&[<=1BSZXM0Y:V
M42D>E85H7RX)Q]D/LOB0:J,$OO@JMD$(-KZ^,>!U_1Y*&0R!&RLHCEE@SZA.
M(F" Y%M<_5LBPA&N=:NXNF[L_'9V(@U-T])E(%GZ8 JA7#/"+))Q5K8AMFF#
MB5ER&_=BS\1.,05UF4$(LF'CGAP0>(KJD-/W6XIY1Z^WTQ/NLL1JFD+76JVV
M/SJ28]6?;4#Q[I> XH>@0-L_I1U*X07QKVN2I,00S(P1&G@/C:=.4<O.U_>Q
MV"ZPX8+/H(SD+VPJ2,- W!$>S%TC#D01'NZ@+M]VS8YR3S7JI\9M?,GN%%9:
M[(C%Z5C.(O4,&\;P!-U##F,J&:V098])*]<&/J&J1\.!'&T;B0<J 9,KO\Q-
MVTG,=SLBUEQY:G@-.:^+"W#J 38NE!:7" 35__BZO>8U,JW(A\S]+^T28RE_
ML+PF$6<?Q-N9W$T?#]JJ-?:@4YY>DA\GF)XM\ X!W'EHG&=+V9,]8DAIN?>5
M?>1L];WUY[83R;5RR;-WR;;Z>"UA%'3=6S$S-SH5L7Q(M6S<B_2(8Z\C2SL=
MZ$T0_JQ%+Z.L9YO5M"V(E23ACZB8),T/9D"CF6=RH*52T9GR<,^71;725_5G
M53LGEJ)+UWLFBH.\@-$$=#<F.X!_"VK_")2,$SZOYAO"H=$",')(.=1SZQ!$
MK@#MX0XOP,1=U09'!X6KU=SM"NIK)P<^6/*2N69^ZSF:\C?YJC[UA#WXNW?N
M/+B9Q@"_)[(F<I%4-3)"+@5WD-3]K_S)8-_&U"(]^Q;S'@3@C*T@C/?#71A@
M"C-$TZ=^59QO+\WM?7R$W0:MK!$P2; L_&3=Z*!4Z_[=NSJ-YWAO:HIJ4B=#
MF-><%,[Q=]\^)"2Y<E$DYS0/>:&[QL6LN@$).*TW(^Z#Z:%;'D=$AJ4_0PYO
M]SSVMZ-'$OD_;@QW2A9>4L_:.9S-S_2\N DNEGAB=8'#]/M@(><8@UXNN%ZN
M2#+/F(@?5E<$7:KS0!0LIQ@G+8=WK><V$)GL$G"D^LH5Z8F1*)&*>"!^.KY[
MP#EAI;&<(NQ<91J.DD'IS9OL%!LEUJZ=$N_((=_&([^Q(RWFL2LJD:^1N.T9
MI#UD;S>/QB<FFI^/8ZE3;=''#=]$O8.V XVZ02@&T=5FM(3HI6RKKZ():E\1
M:;-9^A"->Y=:&F(3Z*_=67>%RMX40\6*74.D[A0SXN=;EHP#LPR"1NQSR9TA
MQG#"COXP 8\\C&9D<?9'*=GX/H4H(RWN[2YQE_31;4J3+2,'!;P4%D1T@#OA
M;<EUBRY%J[GP-;;B(>VMO5D&=O:"GT9RP$HC3\2>!^@FN%\,(.AU-9U$"[_N
MNS!HVUHTTR5/P<J[L*WY&M]_-\)[GQ:MVSKC'PST%P?P*]?-EL%ZKIEMXTG0
M;H3.Y6TBAK9<\M7KP$ U,GHDKRX2R0JD&,RCUS)"\VAN1QQO,)VC'+F#*?HS
M13]Z/T%Z7$3P^[YX6]8N-3B7,BF^ND[VBX_M^4?,!&)S>E@1NWU.4@:"('YZ
M-.E//>465!-5!W.5NI_M-,[T6<>#9WE(_7848]LY#W> G&(B'*WNUJ9>NWR:
MH\^X O?>EXC;AQ(32Q03P?F/SJ4[,/D6$R56:&1DQ1<H>3:O^O@;<*]6+$E]
M=^=$ R[MK^3$K1-PQ$#*DFXH4\;3G<-%E:IB\V:_1B0%J0S,N\XP^)J9.+E;
MX4+JICE.+Q6A0ZQWHCB8-@[[V<?21"(BV%"7/Q&%16KPUUW0@W[CN$PQ6#6,
M2;F0U)7J'UP_BGV2.+\T)C/9^WW5*4B!L*BOCAI6>!B%142!]U0ZL[Z0I][
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M:;]7K="UT%"OXU=\1W&6GA?0$IV@$K=FO<8"*DU ,Y*<2A'-:R4QCPG*RE"
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M\#"\P8#,IK4T\[_^=/(D+B%*(WLHW281P9W'DW,;;#JA$A;,!64'*#^D'\#
MF[@[@K" $?"'I\MF]A:-9A87SCLSCLPOHOH<?OX)MBJNEF:"O_WR.L1N4>YC
M@T8]W/??:AKRWRJL>O@#_!2764BLU=_^\29:*A9G6"YVCG!E<^<]H_](1=1K
M_6PPN)K%4Q#7W%<,8M6B9.@H"L#2!M0<$71SQ0,ET=FI@Y,) T2@E?)1C4LW
M)]G<J'=Z7X1UW<4@W#6W..DL]3.3@Z>@@?ON;?:R;,"_ULT \XZ<Y6L^-GNQ
M.0-C<?RI#CS?PL4IB,E);.??WK:(]\_!!IT6>?:\Q<*/7\#6/,O^#A*CH*^^
MOFRK(ALI)M E@^UXPJMO:BTH]:6)QI3=-?AV58:E<W%%M@OXIMT:\I,"WT@4
M19H]W!/CDXI=ELCLY<)\7J43W<\*O/NL."_ 1*7J!J$6%98NCI6Y$XM4+G\T
MX EG&#!!9Q>%32T9-VLF>$7LL3D-A2"I1+>8(22$9=.EA@DKMN/19M08"CLH
M/A[&G$I%[W.8&N!7 +]].M? =7O<C #6DQHG0_+'!RIT;\-S(S$7V]#2AV^$
M0X:)A"KB_?6%3MZ/U7HS7H/#L)Y8?HL;46$^5 .&M$)!X8A $0I)*&,;,3+^
MYN=5QPVX$4S:M,$!.:(Z:+=0U =+3AN%"+7(^6K^JN-D1UN5"3S*&AF%45'E
MKMD!\N^D/I'9=H"#3^AFS,MB286.N.?6\4R=JOA0D327)T0/P".%Y5O%\&0%
M%J5;-/JTOE.O:D)&W(#C<7HZWB^&ZCL0>-0M+Q.-/3X&,QCW'4@<FLO8SPA4
MGR^6&H\,F?)AVXZ$+Z)ODH>2W3=0#9MY^'*DG*-3Z^)2KR&Y(&4][R+0@WQR
MQ24U_NK;FF[7HLU/5]6=IBKA7L[>RK.H_YJIA_?7[I+ZT3+YP_Q<BFJ;^-D^
MLA8T&O^T4:^SL_?T>,W6B)KRG7N#'::-I[HN;2!F[O[D("01W*-;S5%FB-^P
M>Q]FTQD0+NQ03-7[GE1T%-\XI=0TY>RPC=);SM+.'#PG)[8BW]5OP701B.YR
MP>]TYQ$4ZV(\1!2?00^23RJ,0$DB@XY(Y3.1K\GNA-<@"E:J3U;EIM\8-33%
M^8>MR6S_<TZG54MC:XW@-5/-.V0W=<%SSZZJ;TZL_*>]CG_\L?TZCDKEUL:*
M0A%-&TA97M>6-;%U(\C_[8_&QXZ+>C75;.FS!>XUK6D@XAO^SOT?=C$'S:B[
M=!/W]NT8ZZSY:3+PJO4F3$>L6\/JK<S(9&4%,VRLE>S3(/3*/\-E??N6TQ8)
MIE_G/SB<3@1\5 6$ 3J^"3E/CYHC:(?MT*GY%#S!WJ:4O+8V_,/GO\FSWW#]
M_T<'1DU'\ ?FIVL\?_5/S$T$WR8:6? UN>[!I&ZIS8HY&:2CAT_\?.&'=^]\
M"?Q]J+NV7&ISKJJ3/)^'K3NN2+X3-I?J1>V^R8$TF-Z1NH?(6KZ%5:N %&GN
M@T<Y9S08TW,ZDRM&@KPND%>N[&[]^FY9.B*-NW?NW'4ADG3&#3%!F^5IT2NI
M@[-O*!=';TR 1O1]&;UO<A R9=M49E2H>=<R5[*-33&D4AR\>S+B[^X\M)_$
MIE2.TO(FA/1JA185HKY/1=FM2I<+*T 4UE9N.]VCM02DYN:Q7@K@BJ+V>L0D
M*DLW=S6ZI0LA5352#+-#= _E]*T1TKI(R NKX92[/4A'WY:T#T,8FTT[0ZI2
MA^6'\54"R:!:I0W!Y,:J:&Y@]^KZR)+2BB*4W=%$/UD99*" &35/MP^FB&7"
ME;&M?(EP2RJ)EHPPS7ULHY:R6H6)>7I7K\%% &F-P@TL6-,XF/:*CA4XS5RE
M4+L"4@[JWX*CAZ=1[2\)[3(1HAX9DC\1&\PKD$<L%8[O'-,OO!K_QUBE!I@_
MP?<.9T>'QT<WC#M9K^%TH0'NA!0<(;:1)>#HRBGV[<J1^99YXI.?G(HC3>I@
M4W?ETD4DZ&^3 TL<0X9\PEW=PRUW;11A$%AEE6%*0,KF)*>%0<.B9=: R"(-
MQH1*S''R$0$;(Z19%+;E]$8B)O_Z5[H&(5$L;8N1^G)V5C?+YO32E54BXR><
MZC5+7-32&V:9X_I<C,.5_473OB54<3M'HECX8[/HZ5^3@XL27MD+*[Q:_]*S
M&Z7]E#H#C671GK\1@SA$H=A*A$73\M.$?9W1=MP=>$N=HRG5'^NWJB K/=2[
M.IJ%-->%C3HZB%4^UB9/1SC=G"*O>=L26^V\Q#([^,>;MOD#F6O@M\1$B:'G
M:;.:$O7M\D)!71R@$H0@DE?N#6)4N&NIW08=$Q:&D,I6\KH!Y)\+X'('=,R%
M-)!@CKD$BQ8@]*@N/JA(9D2DUH]4K5\ K&BFC"9S ?C3J8H<(=&G*(ASK2%
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M[A<F@!EK8)L03H9D(EXD(J1,7)#H<@0'5K/9&K@Q',*D$+=^EZRD^ SF<OI
MB%6=K[S4B)@A^;\!"[%M R6*]!/.(Y8]1X.B\\Z-Q. %%8Z2*_:(R)]PM@X8
MX\[9)GJTWK NA!%F%7[65LR12 ]^%&8BL)>6:O@O!%3=7-2.ENWBK*(Z_,!
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M9N'%.=XJ4I3F,C(5QKHGIK8^ FH)U*;3S%ROP&R'OY>WD](@@IC08-YJ(GO
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M&GV*E5&^/Q&U>Y;>"WI("B*2XV,!/"_!\<23YV^*< L^O(- N2ZH7 V7ZO9
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M\^OOFO:4DP1H,"[U0S4&*7./:_S6MQKH%O -$;1Q/X0O8D*<L>/8K@=<?G#
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M@GQ]8= SWVNAP2(3!8OJIO+Z*?K4"@G@]IF@7%3"EOM8&"*UVZIVD_B4F*+
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MP AD*E*.197WE4#;:PPN)!TJA[UCF$BCWFG6Y=$!MRZDY."0'M9]"WGBAB3
MKH49)[85R5 LVCE$SG[O6A3_\GN8F&'3NZ]"$(A: =.W8&,-!X[*TQJVZEDE
M1RC/W8@9/ZM2DUGYS1)ARK88DIQ'X(-8J\/J4_Q24"C7DRAFAHY^&DQZDQ@?
M )_+):^VY@%OMK'SI,%OMJRB,2L#[@@CC820X6# _$X:89FA,5:C9GQ/&+3V
M8A,86I36[+?$2 -!BR(Z[]>7*3L,Y>)AHX:C&>6>-&8"?T]"F?MI&B"1?@,+
M)4RIV??8RT4&2F/P( K "9,$.#>N>[2A<>^JNO8.E=6=4>UCQC5T!SQS_ 5'
MTUG;H(0% THUMK-@1S-EH].1126M'-R?48X6/<4DGBJ*%*3*5_4L8R3R%:=6
M.!LP,6=*1TAK(2D(VH#"S&>&3H8EQ;4=R+.=(G3C-0Q.XO;R^#4A6^#!, HH
M,4&)]T$*.G2:>8?!*$(]=3+L;OO>R_WG</)0,8+PA_^;@$I71!OF)P_N71OT
MZ,&8TOO)\(UW.04-3+2P3O)PJQ]\?^-MO=A_T?)F,HN\VMM_]JJ]M]?R%;<(
MJW]8F-&TI*GY<*JJ82N+5B7*RBOX0;*?^.5/D<)Y^MXYI4&51O@HE"6'"M^S
MD*4R\9'3Z'\G-S1,1?/RY?+ ^_3I$-;SZNKLC7?$W2'5VYB4!NF]V[LOV_(J
MK;X&8!; @OC>'ARDXSA!HEMK%+_C^W=W?!5E58/X&L9QYAW#-;5'XO,PGN_L
M>%\Q-+N'#[T<P_48%Y^ZTW8.@(S:G(,/F(X><^X,3@%L%1R$W?9N:PZ.F=WV
M_K/GK]NOS$G(70;MLUFD2_>^#!&Q,.V_WMD%0P-MV/>@R"G&_2D8PFZ>!F"\
MX0'YBC8<6/M#[_G>R_8KFC=,^0I-GDD*\F4+"0[B-]XIO";+@G^%-TGX#QA#
MA)P]<)RNI]MPN5O;S49M/LMWV+\_8_0C"^+,EC]J&KF@AEL6@7\,XW!T@ZXL
M,J+CZ.:]_B_+S_/O)9?^G\G-T/L4#CIA%SY2?F[5VC0;?\&GMV/^]#\Z,@!:
ME[=S7H_":2N\RTQ[.($7I7+D9LN>W9WGSUZ^V-EYJPZ<[.C,+WZY?'9T>/J/
M 0W[.DTF(YJ2/KAHY,Y[\>RE#8>@AY'Z>CH$U:T.F/KU]L4V_>$?&.'+^O@X
M?.U;[^$+ %?N17MWUXP<;@-HMG,.:!RB3P:'4 WD+L+3/=A.NOR'_$# :W_D
M2%Z:D?PSR2(XZP$VZ04/68WA+_SU=E=^O?"EL*3/*9A/01A[5V 882G T)SJ
M ?]I>ZS^M.!Q[+U\WK*$H/>O\!;DT/$$?"4C=[[A+[?[],MYWO]R9W^.]^^W
M=YZUVWO[K;?6 )J-\@X%=5)*Q%*N1@O^J 63"$Z/).?<XG3U] [MMABBWG'4
MFW0CK-R]")DU++N)1FR:.C&QKH[\90;2F!G M J6I2'%-S#'E:/_@DU1[)3I
M0.B[F@WP,*_'-P+=9<2E4+$IY&9NO6?%%22FX*2N,1S=F58'$[8<ENE\X$8%
MYW1G"$.K9%[=TB6@""S6Q&K$+89H.D+]PQ]XN:G8& /.^&LA/^F[A%R*$8_<
M@9'@2 YTUS&L,<VM.[T<WZ<&6O,H@;_H.!<\+/B.QBF6#DF?)PX9:K2I[JFJ
MZ/Y+VHJYA\;4X&'$C]8R0@@HXL[UPB#,.4R'.BNJFPG8'@ON-YHN"C4P"(AN
M3X'8\1X0)R"935;U$V_Y:)0&48;!/-ZSL;GZI0?%1,.+?6R&B1F,Q@99A275
MAU4S"C!6DQNTYQEP<BF.>49K0I1JZ>PR4^:WL1^!.H\[:J;HLL%SY*8J/* D
MRUQ6]9RCW@E=X).#B%R]/-LE>7;0PX \7VF<#--A7HY@9S(CTI1<L42:D6B>
MP>BB'-$@:]8Y69ZAHN"/<X(>J\*O$8T181-M(<:\3>+)P(X[NV72;NWU5B <
M?22O2LQI(\QJ.NU0=(061: ,F H@#(S*![ 'C\N4X3*Y:)N\F+4;!C_)Z-_+
M3?1O43=NCV[<Y:1CY2__:6F"M]Y7[I(#P@%^C^<4]"'?PC.G/;!5 97O7)"4
M<OFI7\\C&,?RH]3-$&4K7(\>U=9FU..PQUA;U'03OM=$/X3MN'4F.! C!G^I
MI?3E6-!6.DI"&3C#7G-HJ+/@KDV=CZH8J>).%1+B3 K(X=(=T@B44+Y,)CB6
MH?F[]31?0J,R/DM=V<K9PYIA3ICTJ*I35\K8BK>0"M8@.Y$"[B--;5@J2H(-
MC ")S]+;2('6M"A1.O *):5Z!754XG"'JE,;4P:\0_;%5.V*75>D\O*&YD%;
MD1@K2\<.-6=+/0(N*-%%D%W#[%:JF$8S,T0EIZU S.KH$DMWY&'V5ET452BK
M":AZ4+MNBD^=EMU< J;CY)V(HRU">V"]GAANIYS[(5Y*?8Y5.)FVA]ID8<&7
MLX?.D[BWMJJ%YI2IS[D]4 ^F59)!YZ]>V^^3[/E()?"X'I^"N[=(3P<78])=
M.SV=2XA:)K^4ZJ;TKZ_\'5.F'V6CR5@'A\'2)1$U#*C>^@X.69:$U,BL<(S-
M&<=2PGL>:7!8$=R8IY ZQ'$Y]%%<?Q-/^8WJ7U84D]D)R'/V5=8 -R<LHZIE
M*S<.[JH%ZYJH?O"&BUD&*B7@'LCE=E_9<IKD2C14]=X9PWND?@&6Y38<1@0_
M(I),A46B1RJ7CL5D"4MHE61:>5[K.5U(3K5EWI&5?GYO? D]0&6*5R]BL7L1
MZ.945Z=:#DK /:8K):-JCCGL*<WC6]"\V+AZ;F4;B#C$122F\DU7F?EV^9FI
MG%/''$O*8NKM(:M1BUS1#)]G"<'-L!9VSLL:90S*DBX"MLZ0JP8OO&;5D??]
M;72+@0*1ZO4YW3K5\!1/DRN[:.KR49:VY9&_F;:GQHO2?(2:99#-0^E\D5H1
M'57!;/-0./YY'HX9F&WT!O#L. ?P4"]9PX5Y@3U O[P[-)&N;/:MR'4U0OW,
MQ8Y2H*Z>A*:12I2KVB?G[TYDLS2'B\%6)X\+4I^4@R: ,?XE[EYT33:/(B+5
MGQHGUVRD"4$+'<YH3-IM&.J[18C9B,XM2S![8=1DS:AO(RS&ZF;@26,+.>+$
M3Q,8*N6M\Q7GUI^YG!,E23=Q0KM?MB^W=5>&HTMPQ9@2K>_M[NSL^&BCT](<
MF6==V=X'<;/B@ZP/7*J726+_(D2UERFN-;Z1>9!XN'V]#=;\W=TVMI3%\5*,
MV'Q!\O%"1L;H/VU/F%7SLL1:L-F9?WS$+;B3O7AJ?4^D*_W!,TSG!,EEI)/N
M@;P.._"E^*#@9MPJWY(A*5J0*TXZRDXI2(D+T?1SU $(^0U2[%,2V;'N04F
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M(4#(JZ0 F*J7A:U(NQ&5@W?!H8<OI]1AHA]2> L.^%^3WC6W8TDF,2T<QN[
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M=\P.N^T-?^E?W['SFWZ/X60W?0KEIK]L\QBXO4/?.>*F_3KR3U!+ P04
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M8]0B CQ6!)Q"?_!N\AZR6O:+G$::SC-<NW-[;,?2U7]3=K]93+#RXOQ94DO
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M7*HM_5\NTET\^5\/:L]_4$L#!!0    ( ("1CE4+MC3UIP0  ,DJ   4
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M.3 U.&0X:RYH=&U02P$"% ,4    " " D8Y5"COSHKFS  !1S0, $
M        @ &*$P  9#,T.3 U.&1E>#$Q+FAT;5!+ 0(4 Q0    ( ("1CE7Y
M'/F>T L  "0I   0              "  7''  !D,S0Y,#4X9&5X-3$N:'1M
M4$L! A0#%     @ @)&.5?'&.CH- P  #@H  !               ( !;],
M &QN="TR,#(R,3(Q-"YX<V102P$"% ,4    " " D8Y5/" G\54&   41
M%               @ &JU@  ;&YT+3(P,C(Q,C$T7VQA8BYX;6Q02P$"% ,4
M    " " D8Y5"[8T]:<$  #)*@  %               @ $QW0  ;&YT+3(P
D,C(Q,C$T7W!R92YX;6Q02P4&      8 !@!Z 0  "N(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
